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Abstract
The herpes simplex virus is a widespread human pathogen, most commonly known for caus-
ing cold sores. Its infection cycle is initiated with the formation of multiple bonds between
viral glycoproteins and cellular glycosaminoglycans, which are long polysaccharide chains
found close to the cell surface. While the key molecular actors of this initial attachment
have been identified, less is known about the dynamics of the herpes-glycosaminoglycan
interaction.
This thesis focuses on implementing bioanalytical assays to address two main research ques-
tions. First, we investigated how specific physicochemical properties of the glycosaminogly-
can chains and of the viral glycoproteins influence the binding characteristics of the virus, in
particular particle mobility and binding kinetics. Second, we aimed at elucidating how new
progeny virus successfully releases from the cell membrane without getting trapped. To this
end, we used two different cell membrane mimics. The first one consisted of end-grafted
glycosaminoglycan chains, mimicking the native brush-like architecture of glycosaminogly-
cans, while the second one was obtained through incorporation of native membrane material
into supported lipid bilayers. To study virus mobility and measure affinities and binding
forces, we mainly used total internal reflection fluorescence microscopy in combination with
single particle tracking, and atomic force microscopy.
Our results showed that the type of GAG or the glycosylation of the viral glycoproteins
influence the diffusive behavior of herpes simplex virions, which we attributed to a change
in binding forces of the herpes-glycosaminoglycan interaction. Furthermore, we suggest
that a highly glycosylated region, called mucin-like region, found on certain glycoproteins
balances the herpes-glycosaminoglycan interaction to ensure successful release.
Taken together, this thesis provides new insights into the mechanisms regulating attach-
ment and release of the herpes simplex virus to and from the cell membrane, which could
be of relevance to the development of new strategies in antiviral research.
Keywords: herpes simplex virus, glycosaminoglycans, total internal reflection fluorescence
microscopy, single particle tracking, binding kinetics, atomic force microscopy
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1Introduction
“Nothing in life is to be feared, it is only to be understood.” – Marie Curie
Virus is a term that we are all familiar with, inducing fear in most, and fascination in
some. Originating from the Latin word for poison, the term virus is generally used since
the early 18th century to refer to infectious agents∗. The first evidence of the existence of
viruses dates back to 1892, when biologist Dimitri Ivanovsky observed that crushed leaf
extracts from diseased tobacco plants remained infectious after removal of bacteria and
fungi via filtration. Thus, the infectious agent (later discovered to be the tobacco mosaic
virus) had to be smaller than bacteria and fungi, the only infectious agents known at the
time. Indeed, viruses are too small to be visible in an optical microscope, which is why the
first images of viruses could only be obtained after the invention of the electron microscope
in the 1930s.
Today, almost 5000 virus species have been described [1], which is probably only a small
fraction of all existing viruses on earth. They are all around us, residing in water, soil,
air, and of course inside their hosts, which are the organisms they infect. The majority of
these viruses do not cause the damaging effects that they are mostly known for, sometimes
residing within their hosts for a lifetime, without producing any apparent effects at all.
Some viruses have even been suggested to be beneficial to their hosts, providing protection
from other viral diseases or bacterial infections [2]. Yet the most known and, for obvious
reasons, most studied viruses are the ones causing acute disease. Two recent viral outbreaks
have again demonstrated the threat that viruses can present to human health, namely the
Ebola virus outbreak in West Africa between 2014 and 2015, causing more than 10 000
deaths [3], and the Zika virus outbreak in the Americas and the Pacific in 2016.
A virus infection starts with the transmission of a number of virus particles between hosts.
This transmission generally occurs via vectors (insects and ticks for example), via food and
water, or directly from person to person (for example via coughing and sneezing, sexual
∗Since the 1980s, the word virus is also used to describe a self-replicating malicious software (also called
malware), due to its common trait with biological viruses, to replicate only within its host (machine).
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contact, or contaminated objects). Once inside the host, the virus needs to replicate in
order to secure its existence. For this purpose, it hijacks the replication machinery of
cells to produce new copies of itself. These progeny virus particles (also called virions),
then continue to infect new hosts. During the virus infection cycle the cell membrane,
separating the inside from the outside of the cell, plays an essential role. It constitutes a
physical barrier, which the virus needs to cross to gain access to the cellular machinery. To
this end, viruses have adapted to target so-called attachment factors [4], which are molecules
present on the outer cell surface, allowing the virus to bind to the cell membrane, which
triggers a cascade of events eventually leading to cell entry. These attachment factors
frequently consist of carbohydrate groups exposed on the cell surface or in the extracellular
matrix [5]. Many viruses also engage with the cell membrane to release the new progeny
virions from the cell, which requires the initial binding to the cell surface to be overcome
to successfully liberate the virions. The biomolecular interactions between virus and cell
membrane, regulating attachment and release, will be the central theme of this thesis.
This thesis focuses on the herpes simplex virus (HSV), which is a very widespread human
virus, commonly known for causing cold sores [6]. Initial attachment of HSV to the cell
membrane is known to occur via formation of multiple bonds between viral glycoproteins
and sulfated glycosaminoglycans (GAGs) [7], which are long polysaccharide chains present
at the cell surface and in the extracellular matrix. Despite the high frequency of HSV infec-
tions, the exact mechanisms regulating attachment and release remain poorly understood.
In particular, very little is known about the dynamics of the HSV-GAG interaction, which
needs to be reversible to, for example, allow the virus to travel through the extracellular
matrix, and to successfully release from the surface of infected cells.
The main research aim of this thesis was to elucidate the molecular mechanisms regulating
the interactions between HSV and the cell membrane. In particular, two main factors
likely to influence the interaction characteristics were studied, namely the physicochemical
properties of the GAG chains, such as GAG sulfation, as well as the glycosylation of the
viral glycoproteins. Our strategy was to implement two different bioanalytical platforms,
mimicking the architecture of the cell membrane, as complements to traditional cell-based
assays. The first model platform consisted of GAG chains grafted in an end-on config-
uration to a sensor surface, thereby creating a controlled reaction environment to study
HSV-GAG interactions. The second model was derived directly from native cell mem-
branes, and therefore represented a more natural system, which includes the whole range
of membrane components, without relying on the use of live cells. These models were used
in combination with total internal reflection fluorescence microscopy (TIRFM) to mea-
sure HSV binding kinetics and mobility, surface plasmon resonance (SPR), to characterize
the surface functionalization and measure binding kinetics, and atomic force microscopy
(AFM), to measure binding forces of the HSV-GAG interaction.
The remainder of this thesis will be organized as follows: Chapter 2 provides a background
to the biology relevant to this work, while chapter 3 introduces general biophysical con-
cepts. Chapter 4 consists of a short review over different common strategies to study
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virus-cell membrane interactions. Chapter 5 contains the theoretical background of the
main experimental methods and techniques used in the appended papers. Chapter 6
summarizes and discusses the main findings of the appended papers. Finally, chapter 7
concludes this thesis with final reflections and an outlook.
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2Background in biology
“Biology is the study of complicated things that give the appearance of having been
designed for a purpose.” – Richard Dawkins
Understanding life, its nature, origin, and complexity has always been a central theme in
biological sciences. The early beginnings of this discipline were motivated primarily by
people’s curiosity, together with the wish to prevent and treat disease. Over the course
of many generations, humans have built a collective knowledge of living organisms, their
structure, function, and evolution, which we still strive to deepen today. In particular the
technological progress of the past centuries has led to remarkable advances in the field, and
enabled investigations of biological processes at a wide range of length scales.
The first studies of the human body, such as the early investigations of human anatomy in
ancient Egypt and Greece [8], were conducted at the meter scale. An important milestone to
decrease the length scale of biological studies was the invention of the optical microscope
in the 17th century, which allowed the direct observation of cells and bacteria in the
micrometer range. Today, thanks to advanced high-resolution technologies, we can study
biological processes at the nanometer scale. Here we find the macromolecules essential to
all living organisms. Four classes of macromolecules have been defined as the fundamental
building blocks of life [9]: proteins, carrying out a vast number of functions within organisms,
including catalysis of vital chemical reactions, carbohydrates, used for example for energy
storage, lipids, providing structure to cell membranes, and nucleic acids, responsible for
storing, transmitting and expressing genetic information.
This thesis focuses on the nanometer range, which is the length scale of viruses and the
cell membranes they interact with during infection. This chapter provides the biological
background of the different actors in virus-cell membrane interactions. First, the cell
membrane is introduced, with a focus on three of the fundamental building blocks: lipids,
proteins, and carbohydrates. Then, the general structure of viruses and the viral replication
cycle are presented. Finally, the last section is dedicated to the herpes simplex virus, and
the current knowledge about its interactions with the cell membrane.
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2.1 The cell membrane
The cell membrane, also known as plasma membrane, is an essential component of the cell.
It separates the content of the cell from the outer environment and acts as a barrier that
controls the passage of molecules in and out of the cell. The cell membrane is a dynamic
and flexible structure, built up mainly from lipids and proteins (figure 2.2).
Membrane lipids are amphiphilic molecules. They consist of a hydrophilic (polar) head
group and a hydrophobic (nonpolar) hydrocarbon tail domain. In order to minimize the
contact between the hydrophobic region and the surrounding water molecules, lipids ar-
range into distinct supramolecular assemblies when placed into an aqueous environment at
a high enough concentration. The structure of these assemblies depends on the geometry
of the lipid molecules, often characterized by the critical packing parameter (CPP) [10;11]
v/a0lc, where v is the volume of the hydrocarbon tail domain, a0 the cross-sectional head
group area, and lc the maximum effective length of the hydrocarbon chain. For a CPP
close or equal to one, the lipid has a cylindrical geometry, and its preferred self-assembly
structure is a double-layered sheet, called bilayer (figure 2.1), with the hydrophobic hydro-
carbon chains sandwiched between the hydrophilic head groups. The ∼ 5 nm thick lipid
bilayer is the basic structure of the cell membrane, accounting for approximately half of the
mass of most animal cell membranes [12]. The most abundant lipids in the cell membrane
are the phospholipids, whose general structure consists of the hydrophilic head and two
fatty acid tails (figure 2.1).
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Figure 2.1: Membrane lipids are amphiphilic molecules consisting of a hydrophilic head
group and a hydrophobic tail region. The most abundant membrane lipid is the phospholipid,
whose hydrophobic part comprises two fatty acid tails. The preferred self-assembly structure
of the lipid depends on the critical packing parameter (CPP). A CCP close to one confers a
cylindrical geometry to the lipid, resulting in lipid bilayer structures, such as the lipid vesicle
or lipid bilayer.
The remaining half of the membrane mass mainly comes from the membrane proteins that
are responsible for most of the membrane’s functions. These proteins are very diverse
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in structure and in the way they are attached to the membrane. Some are covalently
linked to the lipid bilayer and reside in the cytosol or in the extracellular matrix. So-called
transmembrane proteins on the other hand are amphiphilic molecules and span across the
whole membrane (with the hydrophobic parts being oriented towards the hydrocarbon
tails of the lipids). The structure of a membrane protein is directly linked to its function.
Transmembrane proteins are for example responsible for the transport of molecules across
the membrane. Other proteins (both transmembrane proteins or proteins on the outer
cell surface) serve as receptors for signaling molecules outside of the cell. The binding
of a molecule to a receptor protein then usually results in a physiological response of the
cell.
The concept of a fluid membrane was first introduced in the early 1970s by Singer and
Nicolson, who proposed a so-called fluid mosaic model to describe biological membranes.
According to this model, the cell membrane is a two-dimensional fluid, made of proteins
embedded in a lipid matrix [13]. The concept of fluidity was of great importance for the un-
derstanding of the structure and functionality of biological membranes. Individual lipids
can diffuse within the cell membrane with lateral diffusion coefficients on the order of
10−8 cm2/s [14]. The lateral diffusion of membrane proteins is very variable, but can be esti-
mated to be around 1-5 orders of magnitude slower than membrane lipid diffusion [15].
Singer’s and Nicolson’s model turned out to be too simplistic and was therefore refined in
1982, when Karnovski et al. demonstrated that lipid molecules are, despite their lateral
mobility, not homogeneously distributed in the membrane. They suggested that lipids form
tightly packed microdomains within the membrane, thus creating heterogeneous structures
of high significance for the functionality of the membrane [16]. For example, microdomains
rich in sphingolipids and cholesterol, commonly referred to as membrane rafts, have been
suggested to be involved in a wide range of processes, such as cell signaling, host-pathogen
interactions, and a variety of disease conditions [17–19]. Although their existence still remains
a controversy [20], membrane rafts could play an important role during viral infection, as
viruses could exploit these domains as gateways for successful cell entry or exit [21;22].
2.2 Carbohydrates
Carbohydrates, also referred to as glycans or sugars, are the third building block of cells.
They are one of the major components of the extracellular matrix (ECM), a layer of
extracellular macromolecules extending from the membrane and surrounding all eukaryotic
cells. Carbohydrates are also found attached to the cell membrane, all-together forming the
glycocalyx, a layer of high complexity, which plays a key role during the cell’s interactions
with its surroundings. Unlike proteins, carbohydrates are not coded for in the cellular
DNA, but are synthesized by the cell via enzymatic reactions. An interesting characteristic
of carbohydrates is that they reflect certain disease states of the cell. For this reason,
carbohydrates can be used as biomarkers for certain physiological conditions [23].
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Figure 2.2: Illustration of the cell membrane containing lipids and proteins, together with
the extracellular matrix, displaying collagen, proteoglycans and glycosaminoglycans.
Carbohydrates exist in different forms (figure 2.2): They can be attached to proteins, lipids,
or secreted freely into the extracellular space. The addition of one or more monosaccha-
ride units to a protein or lipid is called glycosylation [24]. This process confers additional
information, structure and function to these molecules. More than half of all proteins are
glycosylated [24]; they are then called glycoproteins. The carbohydrate groups on these
proteins are either N -linked or O-linked, depending on the element the sugar unit is linked
to (nitrogen or oxygen). Glycolipids, which are glycosylated lipids, represent 1% of all
lipids found in a generic mammalian cell [25]. The head group of these lipids is formed by
the monosaccharide units, meaning that the glycans are oriented towards the ECM. The
most abundant glycolipids in mammalian cells are glycosphingolipids. They play a role in
cell-cell recognition, cell surface reception, and messaging [25]. Some carbohydrates occur as
long, unbranched polysaccharide chains, composed of repeating disaccharide units. These
chains are either attached to a protein core (called a proteoglycan) or secreted freely into
the ECM.
The glycan structures that we will focus the most on in this thesis are the glycosamino-
glycans (GAGs). They are the main form of polysaccharides in mammalian cells. These
long linear sugar chains are found both at the cell surface and in the extracellular ma-
trix, therefore often serving as receptor sites for diverse biomolecules and pathogens. They
also modulate cell adhesion, differentiation, migration, and proliferation [25]. Despite their
structure made from repeating units of disaccharides (figure 2.3), GAGs are highly hetero-
geneous molecules. This is due to postsynthetic modifications of the chain, which mainly
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consist of an addition of sulfate groups. The sulfation patterns on the GAG chains have
been shown to be specific for certain tissues, development stages of the cell, and disease
conditions [26;27]. As we will discuss later, the sulfation motifs on the chain (“sulfation code”
of the GAG) also influence the interactions with viruses [28]. In this work, we focus on
three different types of GAGs: hyaluronic acid/hyaluronan (HA), heparan sulfate (HS),
and chondroitin sulfate (CS). HA is not sulfated and therefore has the simplest chemical
composition. With up to 10 000 disaccharide units, it is by far the longest GAG that
exists. Unlike HS and CS, HA is not bound to a protein core. HS and CS are made of
10 to 100 disaccharide units [29]. They differ in their disaccharide units, their sulfation pat-
terns and their location in the ECM or on the cell surface. HS is mainly found attached
to membrane proteoglycans (for example perlecan, agrin and syndecan). Syndecan also
carries CS chains. In contrast, around 100 CS chains are covalently bound, in a brush-like
configuration, to the proteoglycan aggrecan, present in the ECM and thus located further
away from the cell membrane [30] (figure 2.2).
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Figure 2.3: Molecular structure of glycosaminoglycans used in this thesis work: hyaluronan,
chondroitin sulfate, and heparan sulfate.
As already mentioned, glycoconjugates often serve as attachment factors for viruses [31].
For example, a variety of viruses, such as influenza, take advantage of sialic acid residues
on the cell surface for initial attachment [32]. Another important class of viruses bind to
GAGs. Well-known examples are the human immunodeficiency virus (HIV) [33], the Ebola
virus [34], the Zika virus [35], the human papillomavirus (HPV) [36], and the herpes simplex
virus (HSV) [7]. The sulfation code of the GAGs and their location in the ECM play an
important role in this binding process, as we will discuss further in this thesis.
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2.3 Viruses
A virus is by its simplest definition a small infectious agent that uses the cell’s replication
machinery to produce new copies of itself. It can infect all species found on earth, from
animal cells, to plant cells and bacteria. The diameter of a single virus particle, called
virion, is in the nanometer range, with the smallest virus being around 20nm (parvovirus).
So-called superviruses can have characteristic diameters up to half a micrometer: the largest
known virus, the mimivirus, has a diameter of about 400 nm with 100 nm long filaments
extending from the capsid [37;38].
The general structure of a virus consists of a protein shell (also called capsid) protecting
the viral genome. The genome can be either DNA or RNA and both can be either single
or double stranded. Some viruses are enveloped, which means that a lipid membrane
surrounds the protein capsid. This membrane is derived either from the plasma membrane
of its host cell or obtained from one of the inner membranes of the cell. The viral lipid
envelope embeds one or more species of proteins involved in different stages of the virus
replication cycle, notably virus attachment, entry and release. These proteins are often
glycosylated, therefore commonly referred to as glycoproteins.
Although viruses are generally not considered to be living organisms because of their in-
capacity to reproduce autonomously, their continued existence requires reproduction, just
like for any living organism on earth. In order to reproduce, viruses infect host cells, which
turn into virus-producing factories. The replication cycle of a virus (figure 2.4) is divided
into different steps [38]: The first step is the attachment, during which viral proteins bind
to specific attachment factors present on the cell surface. More viral proteins and cellular
factors then come into play for successful virus entry into the cell. The virus enters the
cell either by endocytosis (a process during which the plasma membrane bends around the
virion and pinches off into the cytoplasm) or by fusion of the viral envelope with the cell
membrane. Once inside the cell, the virus has to synthesize new viral components and
replicate its genome. Synthesis of new components is done by transcription of the genetic
information into messenger RNA, translation of this information into sequences of amino
acids to form new proteins, and transport of viral components to different locations within
the cell. Genome replication usually takes place in the cell nucleus but can also be carried
out in the cytoplasm for certain viruses (most RNA viruses). Finally, the different viral
components assemble to form new virions that exit the cell in the final step called egress.
For enveloped viruses, egress can occur via budding at the plasma membrane, which is
enriched with specific viral proteins. In this case, the virus acquires its viral envelope by
deforming the membrane into a bud enveloping the rest of the viral components. Some
viruses acquire their envelope by budding through the nuclear membrane. They are then
transported out via vesicles that fuse with the plasma membrane. In certain types of
infection cell lysis occurs to release the progeny virus.
How specific a viral infection is to the cell that is infected generally depends on the type
of virus. A cell that can be infected by a certain type of virus and permit its replication
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Figure 2.4: Illustrative overview of the virus replication cycle based on the replication of the
herpes simplex virus. After initial attachment to the cell membrane (1), the virus enters the
cell (2) via endocytosis or fusion (as shown here). Viral components are transported to their
respective replication sites (3). Genome replication (4) can take place either in the nucleus
or in the cytoplasm. After assembly of the new viral components (5), the progeny virus leaves
the cell in the final step called egress (6).
is called a permissive cell. A permissive cells needs to meet a series of requirements for
successful virus infection [38]: First of all the cell membrane must have attachment fac-
tors and entry receptors specific for that type of virus. Second, the cell must contain all
the components necessary for virus replication (proteins and enzymes for example). This
last requirement generally restricts the number of permissive cells for viruses with small
genomes that almost entirely depend on the cell’s replication machinery to copy their
genome. Viruses with larger genomes are usually able to synthesize their own proteins and
enzymes needed for the replication process inside the cell [37].
The fate of an infected cell depends on the type of virus infection, which can be divided
into four groups [37]: Acute or lytic infections produce new virions at a high rate and result
in rapid cell death. Persistent or chronic infections are long-term infections with a slow
virus production. In latent or proviral infections, the viral genome resides in an inactive
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state within the cell. Finally, in transforming infections, the cell’s growth properties and
phenotype are altered, which can for example lead to the development of cancer.
(a) (b)
Figure 2.5: Herpes simplex virus. (a) Illustration showing the structure of HSV: The viral
DNA is protected by an icosahedral protein cage, called capsid. The capsid is surrounded
by a lipid envelope carrying the glycoproteins. The tegument, a cluster of proteins, fills the
space between capsid and envelope. (b) Electron microscopy image of HSV-1 KOSc. Image
acquired by Edward Trybala and Sibylle Widehn.
2.4 The herpes simplex virus
The herpes simplex virus (HSV) belongs to the herpesvirus family (also called herpesviri-
dae), which is characterized by large enveloped DNA viruses. The herpesvirus family can
be divided into three subfamilies: alphaherpesviruses (including herpes simplex virus type
1 (HSV-1), herpes simplex virus type 2 (HSV-2), and the varicella zoster virus), betaher-
pesviruses (including the cytomegalovirus, and human herpesvirus 6A, 6B and 7), and
gammaherpesviruses (including the Epstein-Barr virus and Kaposi’s sarcoma-associated
herpesvirus). The name of this family of viruses originates from the Greek word herpein,
which means to creep, referring to the common characteristic of herpesviruses to cause
life-long latent infections in their hosts [39].
This thesis focuses on the herpes simplex virus and its two serotypes HSV-1 and HSV-2.
HSV is most commonly known for causing blisters on the skin or mucosa of the lips, mouth
or genitals. While HSV-1 and HSV-2 preferentially reactivate from oral and genital sites
respectively, both serotypes are able to infect either site [40]. HSV-1 is the more common
infection (67% of the world population under the age of 50 is estimated to be infected [41]),
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and primary infection often occurs during childhood (through contact with saliva or breast
milk). HSV-2 being transmitted mainly via sexual contact, primary infection usually occurs
later in life. For HSV-2, 11% of the world population aged 15-49 is estimated to be
infected [41]. Both serotypes can cause lytic infections in fibroblasts and epithelial cells of
the affected areas (oral or genital sites), and establish latency in neuron cells from which
they can periodically reactivate.
HSV is an enveloped virus with a double-stranded DNA genome (figure 2.5a) enclosed by
the protein capsid. With around 150 kilo base pairs [42;43], the genome of HSV is relatively
large, which means that it encodes for a large number of different proteins. The viral
envelope embeds twelve different species of glycoproteins, which all play a specific role in
one or several virus replication steps [44]. The linker between capsid and envelope is the
tegument, a cluster of proteins common to all herpesviruses.
Virus attachment is mediated by glycoproteins gC and gB binding to cell surface heparan
sulfate (HS) and chondroitin sulfate (CS). gC-1 (glycoprotein gC of serotype HSV-1) is the
main attachment protein of HSV-1 and it binds to HS [45] and CS [46;47]. It is however not
essential for successful cell infection, since it has been shown that gB-1 mediates binding
for gC-1 deficient HSV-1 virions [48]. The situation is different for HSV-2, where gB-2 (gly-
coprotein gB of HSV-2) has been suggested as the main attachment protein [49;50]. Virions
that are deficient in both gC and gB show drastically reduced infectivity [48]. This has
however been proposed to be partially due to the need of gB for viral entry [51]. Fusion
between the viral envelope and the plasma membrane (figure 2.4) has been suggested as
the main pathway for HSV entry into the cell [51]. It is triggered by glycoprotein gD (and
additionally gB and gH/gL heterodimers) binding to entry receptors on the cell membrane.
Three different classes of entry receptors have been identified [52]: HVEM (herpesvirus entry
mediator), nectin-1 (both serotypes) and nectin-2 (HSV-2 only), as well as 3-O-sulfated
HS (HSV-1 only). After fusion, the nucleocapsid (viral capsid containing the DNA) and
tegument proteins are released into the cytoplasm of the host cell. An alternative pathway
for viral entry via endocytosis and fusion at low pH with the endosomal membrane has
been shown for HeLa and CHO cells [53], thus suggesting that HSV has two distinct path-
ways for viral entry, depending on the host cell. The nucleocapsid is transported to the cell
nucleus where replication and transcription of the viral DNA, as well as assembly of the
nucleocapsid takes place. To assemble a new virion a series of events follows [38](figure 2.4):
First the nucleocapsid containing the viral DNA buds through the inner nuclear membrane,
where it acquires a temporary envelope. This envelope then fuses with the outer nuclear
membrane, releasing the nucleocapsid into the cytoplasm, where it gets coated with the
tegument proteins. The capsid/tegument complex then acquires its final envelope by bud-
ding into a vesicle from the trans Golgi network (TGN), which expresses the glycoproteins.
Finally, the TGN vesicle fuses with the plasma membrane to release the virion from the
cell.
In this work, we focus on two key steps of the HSV replication cycle: the initial attach-
ment of the virus to the cell membrane and the release of the progeny virions from the
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cell membrane. These two processes are closely linked to each other: while the initial
interactions between virus and cell membrane are essential to achieve viral entry, these
same interactions must be overcome in order to ensure successful detachment of the newly
produced virions from the cell membrane. Poor detachment would lead to trapping of the
progeny virions on the surface of the infected cell, and result in a dead-end infection. To
avoid trapping, the sialic acid binding influenza virus produces an enzyme (neuraminidase)
that degrades sialic acid moieties on the cell surface, thereby facilitating virion release [54].
A similar mechanism, based on the HS degrading enzyme heparanase, has recently been
suggested for HSV-1 [55]. Hadigal et al. indeed demonstrated that HS expression on the cell
surface is drastically decreased after HSV-1 infection and that this effect is a result of an
upregulation of active heparanase upon infection. It is interesting to note that the genome
of the influenza virus encodes for its receptor degrading enzyme neuraminidase, while HSV
is not known to encode for any enzymes, but would take advantage of a host-enzyme to
facilitate viral egress.
In this thesis we will discuss an alternative mechanism for regulation of attachment and
release of HSV, related to the glycosylation of the viral glycoproteins. Viral glycoproteins
are synthesized and glycosylated by the host cell machinery. Accordingly, the glycan struc-
tures found on the virus envelope are similar to those of cellular glycoproteins, consisting
of N -linked or O-linked oligosaccharides [56]. It has been suggested that viruses take advan-
tage of this similarity to protect themselves from the host’s immune response, based on the
idea that viral antigens, strongly resembling cellular structures, are more easily tolerated
by the immune system [57;58]. HSV, among others, has been found to present regions of
numerous clustered O-linked glycans on certain glycoproteins, structurally resembling the
glycosylation of mucins. These so-called mucin-like regions form extended structures, com-
prising multiple negatively charged sialic acid residues, and covering substantial parts of the
underlying and neighboring proteins. Therefore, mucin-like domains have been suggested
to shield viral binding sites from unwanted or premature interactions. In paper II and
paper III we investigate the role of a mucin-like region found close to the GAG-binding
site on gC-1 [59], which has been shown to affect binding kinetics of gC-1 to immobilized
HS [60]. A similar structure has also been found on glycoprotein gG of HSV-2. Paper IV
discusses its potential role in viral egress.
14
3Concepts in biophysics
“Nothing happens until something moves.” – Albert Einstein
Nature is governed by universal laws of physics. Four different fundamental forces have
been identified to rule over everything that surrounds us. For example, lightning strikes
during thunderstorms are caused by electrostatic forces emerging between positively and
negatively charged regions in a cloud, and apples falling from trees are believed to have
inspired Newton to formulate the theory of gravitation. The fundamental forces apply to
the very big scales, describing the movement of planets and galaxies for example, but also
to the very small scales, explaining how the nucleus of an atom holds together.
In the same way that atoms and planets obey the laws of physics, living matter does too.
In fact, all processes regulating life are ruled by physics (entropy, for example, plays a
particular role, which we will come back to soon). This highlights the importance and
need of studying biological processes from a physicist’s point of view.
This chapter aims to familiarize the reader with a few biophysical concepts of importance in
this thesis work. We start with the basic concepts of thermodynamics and their importance
in biology. We then discuss specificity and multivalency of receptor-ligand interactions and
describe the formalism of binding kinetics. This is followed by a section dedicated to single
particle diffusivity and tracking, a further topic of direct relevance to this thesis.
3.1 Thermodynamics
The cell is the fundamental unit of structure in all organisms. It is a very dynamic entity
that is constantly changing. An equilibrium state, from a classical physics perspective, is
therefore difficult to apply to any biological system. Nevertheless, the processes happening
inside the cell occur at very different time scales, which makes it possible to consider
isolated “quasiequilibrium” states ruled by the laws of thermodynamics [9].
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Cells need to store and transform energy to be able to carry out vital reactions. The
source of energy is food (fats, proteins, carbohydrates), or sunlight for plant or bacteria
cells for example. During this process, the law of conservation of energy (first law of
thermodynamics) has to be fulfilled. To help us describe the thermodynamic state of
a cell, we need to introduce two important concepts, namely the concept of free energy
minimization and the concept of entropy. The Gibbs free energy is defined as follows:
G = H − TS (3.1)
The enthalpy H is the internal energy of the system and T is the temperature. S is the
entropy of the system. It is a measure of the disorder of a system, or, more precisely,
a measure of the number of microscopic configurations a system can exist in for a given
macroscopic state [9]:
S = kB lnW (3.2)
where kB is the Boltzmann constant and W is the number of microstates.
Every system strives for minimizing its free energy and an interaction takes place sponta-
neously only if ∆G < 0. With this in mind, the equilibrium state of a biological system
is defined as the macroscopic state, out of all possible states, which minimizes the Gibbs
free energy. If we consider an isolated system (constant internal energy and mass), the
minimization of the Gibbs free energy (∆G < 0) translates into a maximization of the
entropy of the system (∆S > 0), which is known as the second law of thermodynamics.
This implies, that the macroscopic equilibrium state of an isolated system will be the one
that allows for the highest number of microscopic configurations.
One concept of great importance in biophysics, which can be explained by the second law
of thermodynamics, is the hydrophobic effect [9]. When placing a nonpolar molecule in
water, the water molecules in the vicinity of the nonpolar molecule are restricted in their
formation of hydrogen bonds. The number of microscopic configurations of these water
molecules, and thus the total entropy of the system, is thereby reduced. To minimize this
entropy loss, nonpolar molecules tend to aggregate or phase separate when placed in water.
This is known as the hydrophobic effect. It explains, for example, why water and oil do
not mix, the arrangement of lipids into well-defined structures such as micelles or bilayers,
as well as protein folding.
3.2 Intermolecular interactions
As we discussed earlier, there are four known fundamental forces, also called fundamental
interactions. Each of them acts over a characteristic range. For example, the electromag-
netic and the gravitational forces have a long range of action, which consequently makes
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them apparent at our (human) scale. In contrast, the strong and weak interactions are
short-range interactions, acting over a distance of approximately 10−15 m. Although invis-
ible to the human eye, they are indispensable, as they become predominant at the length
scale of elementary particles.
The forces that emerge between atoms (belonging to the same or to two different molecules)
can be of different nature depending on the physical properties of the atoms (charge and
polarity for example) and the interatomic distance. The strongest intermolecular (or in-
tramolecular) interactions are the covalent bond and the electrostatic force. The covalent
bond is a chemical bond formed by the sharing of electrons between atoms with a strength
of 100 − 300 kBT per bond, and a range of 0.1 − 0.2 nm [10]. The electrostatic force, or
Coulomb interaction as it can also be referred to, is a physical force emerging between two
charged atoms. The strength of this interaction is on the order of 200 kBT for monovalent
ions such as Na+ and Cl− [10]. One fundamental difference between the covalent bond and
the electrostatic force is the directionality of the interaction. The covalent bond is a direc-
tional force, meaning that the molecules orient themselves in well-defined angles relative to
each other. The electrostatic force on the other hand is non-directional and therefore less
specific than the covalent bond [10]. Other examples of non-directional forces involved in
intermolecular interactions are van der Waals forces, hydrophobic interactions, hydrogen
bonds and electric dipole interactions [10].
Intermolecular forces occupy a central role in the context of this thesis, as they drive the
biomolecular interactions occurring between different binding partners (for example viruses
and cellular attachment factors) that we probed in the appended papers. When character-
izing biomolecular interactions, one often refers to the specificity of the interaction, which
is defined as the ability of that interaction to occur only between a biomolecule A and
another biomolecule B. If A is also able to bind to a third biomolecule C, but prefers
to bind to B, we talk about selectivity instead. High specificity can also be achieved for
non-directional forces if the three-dimensional arrangement of the two binding partners is
favorable to that interaction (figure 3.1a). This is for example the case for antibody/antigen
interactions [61].
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Figure 3.1: Illustration of the concept of specificity and multivalency. (a) Non-directional
forces can achieve high specificity if the three-dimensional arrangement is in favor of the inter-
action. (b) Multivalent interactions can be collectively stronger than the separate monovalent
interactions they are composed of.
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Biomolecular interactions are often of multivalent nature, which means that they are cre-
ated by simultaneous interactions between multiple binding sites on one entity and multiple
binding sites on the other (figure 3.1b). This can lead to interactions that are collectively
stronger and of higher selectivity than the monovalent interactions they are composed
of [62]. Furthermore, the multivalent nature of an interaction could enhance the dynamics
of certain biological processes, as several weak bonds can more easily be broken and re-
formed than a single bond of the same overall strength. Multivalency plays an important
role in the context of recognition processes at the cell surface. Cell-to-cell adhesion, the
attachment of bacteria to cells, and binding of extracellular vesicles are a few examples of
multivalent interactions occurring at the cell surface [62;63], but it can be hypothesized that
any molecule that comprises several binding sites relies on multivalency to interact with the
cell membrane. The overall strength of such multivalent interactions is directly influenced
by the number of bonds that are formed between the binding entity and the cell membrane,
and can thus be related to the density and spatial arrangement of binding sites on the cell
surface. For this reason, cells could benefit from multivalency to control the interactions
the cell membrane engages into and protect the cell from undesired interactions.
Multivalency is a central concept in this thesis. Indeed, considering that viruses usually
present several copies of binding proteins on their capsid or envelope, it is generally believed
that the interaction between a virus and the cell membrane is of multivalent nature [62]. For
example, multivalency has been studied for Simian virus 40 [64–66], influenza [62], and HSV [67].
How exactly viruses take advantage of multivalency during attachment to the cell surface
and entry remains to be further investigated. Nevertheless, it can be hypothesized that
the formation of multiple bonds between the virus particle and the cell membrane confers
stability and increased strength to the interaction, which could be a prerequisite for viral
entry. Furthermore, because of a higher capacity of breaking and reforming bonds, viruses
could use diffusive mechanisms to travel along the cell surface in search for suitable entry
sites [68]. Finally, the formation of multiple bonds with the cell surface could trigger the
deformation of the membrane, necessary for particle uptake [69].
3.3 Quantifying binding kinetics
Besides specificity, selectivity, and multivalency, biomolecular interactions are characterized
by their affinity. The affinity is a measure of the strength of the interaction. It is related to
the binding and unbinding rates (also called on and off rates, respectively) of the reaction
describing the formation of a bound complex from two binding entities. The formalism to
quantify these rates will be presented in this section.
We will first consider a simple interaction between one binding entity, herein called ligand
L, and another one called receptor R, forming the complex LR. Since the assays used
in this work are all based on the recognition of biomolecular interactions occurring close
to a surface, we will focus here on the case of ligands in solution, binding to receptors
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immobilized on a surface (figure 3.3a).
L + R
kon−−⇀↽−−
koff
LR (3.3)
kon and koff are the reaction coefficients for binding and release respectively, also called
association and dissociation rate constants. They can be related to the activation energies
∆Eon/off of association and dissociation respectively using the following expression:
kon/off = A exp
(
−∆Eon/off
kBT
)
(3.4)
T is the temperature of the system and A represents the number of collisions per unit time
and concentration of ligands in the case of kon, and the number of dissociation attempts
per second for koff . We define the equilibrium dissociation constant KD = koff/kon, which
is expressed in molar and has a low value for a high affinity interaction. It can be related
to the Gibbs free energy (see figure 3.2):
KD = koff/kon = A exp
(
−∆Eoff −∆Eon
kBT
)
= A exp
(−∆G
kBT
)
(3.5)
Energy
Reaction progression
L+R
LR
ΔE
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Figure 3.2: Arrhenius plot: The reaction constants for association and dissociation can be
related to the activation energies for both processes and thus to the Gibbs free energy according
to equation (3.4) and (3.5).
The rate of binding depends on two mechanisms: the rate of reaction, i.e. how fast the
reaction between L and R occurs, and the diffusion of the ligand molecules in solution,
i.e. the mass transport. One of these processes usually occurs much faster than the other,
making one the limiting factor of the binding event. For this reason a system is either
classified as reaction-limited or diffusion-limited (mass transport-limited) [70].
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To quantify binding kinetics in a reaction-limited system, we consider the Langmuir model,
which assumes fast diffusion and reversible binding (continual association and dissociation
of ligands). The number of ligands bound to a receptor per unit area is given by Θ(t) and
the rate of change is written as:
dΘ(t)
dt
= konC(Θmax −Θ(t))− koffΘ(t) (3.6)
C is the concentration of ligands in solution and Θmax is the total number of surface-bound
receptors per unit area.
To solve this differential equation we consider two cases of different boundary conditions.
The first case is association to an empty surface Θ(0) = 0. The solution is then given
by:
Θ(t) =
konCΘmax
konC + koff
[1− exp(−[konC + koff ]t)] (3.7)
This expression is known as the Langmuir isotherm. At t → ∞ equilibrium is reached,
meaning that the rates of binding and release are equal. Equation (3.7) then becomes after
rearrangement:
Θeq
Θmax
=
C
C +KD
(3.8)
For dissociation, the boundary condition becomes Θ(0) = Θeq and we have C = 0. The
solution of equation (3.6) is then expressed as an exponential decay:
Θ(t) = Θeq exp(−koff t) (3.9)
The reaction in (3.3) describes a simple monovalent interaction of two binding molecules
of equilibrium dissociation constant KmonoD . If we consider n independent monovalent
interactions, the total equilibrium dissociation constant is given by [62]:
KmultiD = (K
mono
D )
n (3.10)
However, in the case of two multivalently interacting binding entities (forming n bonds),
the individual interactions are not necessarily independent, but present a certain degree
of cooperativity α. The concept of cooperativity was introduced to describe a situation
where the formation of additional bonds is either facilitated or hindered by the creation of
the first bond. α > 1 indicates positive cooperativity, which means that each additional
bond forms more easily than the previous one and the overall affinity (also called avidity) is
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Figure 3.3: Illustration of the Langmuir model. (a) Ligands in solution bind to and release
from receptors immobilized on a surface. (b) The fractional coverage expressed as a function
of time can be divided into three parts: 1. Association of ligands to surface-bound receptors
2. Equilibrium conditions (total rate of change is zero) 3. Exponential decay of bound ligands
during rinsing step (no ligands in bulk solution).
higher than in the case of independent bonds (KmultiD < (K
mono
D )
n). α < 1 indicates negative
cooperativity, for which KmultiD > (K
mono
D )
n. To account for cooperativity, equation (3.8)
can be generalized to:
Θeq
Θmax
=
Cα
Cα +Kα0.5
(3.11)
which is known as the Hill equation [71;72]. For α = 1 (no cooperativity) K0.5 = KD
(equations (3.8) and (3.11) become identical).
The Langmuir model (figure 3.3b) does not take into account the depletion of ligand
molecules close to the surface. If ligand molecules diffuse slowly, this depletion zone is
larger and the system is diffusion limited. In that case, the number of bound ligands per
unit area is given by the Ilkovic equation [70]:
Θ(t) = 2C0
√
Dt
pi
(3.12)
C0 is the concentration of ligands in the bulk solution, and D represents their diffusion
coefficient, as defined in section 3.4.
It is worth recalling that the rate of change in equation (3.6) includes both on and off
rates. Techniques based on ensemble averaging (like surface plasmon resonance for exam-
ple, described in chapter 5), can not dissect pure association and dissociation signals from
21
CHAPTER 3. CONCEPTS IN BIOPHYSICS
the overall binding curve. However, association and dissociation can be analyzed inde-
pendently of each other using techniques capable of single particle detection. This is the
case for equilibrium fluctuation analysis (EFA) [73], a method based on total internal reflec-
tion fluorescence microscopy (see chapter 5) that we used in this work. With this method,
time-lapse movies of single particles interacting with the surface are analyzed. The software
counts, for each frame, the number of newly bound and released particles, and determines
the residence time of each individual particle. Association curves are generated directly
from the cumulative plot of newly bound particles over time, while dissociation curves are
constructed based on the individual residence times of the dissociated particles.
The slope of the association curve (also called association rate) generated by EFA is given
by
dN+
dt
= kon Nfr C (3.13)
Nfr = Θmax−Θ(t) represents the number of free surface receptors per unit area. Equation
(3.13) is derived from equation (3.6) after eliminating the negative release term. Assuming
an excess of free surface receptors (i.e. Θmax  Θ(t) in equation (3.6)), we obtain:
dN+
dt
= kon Nr C (3.14)
where Nr is the total number of receptors on the surface per unit area (representing Θmax).
Equation (3.14) shows that the association rate is directly proportional to the association
rate constant kon.
The dissociation curve obtained from EFA can be written as:
N(t) = Neq exp(−koff t) +Nirr (3.15)
where Neq represents the total number of associated particles per unit area, and Nirr the
number of irreversibly bound particles per unit area.
3.4 Diffusivity and single particle tracking
When microscopic particles are suspended in a fluid, they move randomly in the solution.
This movement is called Brownian motion, named after the botanist Robert Brown, who in
1827 observed pollen grains in water under a microscope and saw small particles randomly
moving in the cavities of the pollen grain, filled with water. The underlying mechanism
behind this motion was described 78 years later by Albert Einstein. He suggested that the
observed random movement of suspended particles in solution is due to collisions with the
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surrounding molecules of the solution [74]. The latter ones are in constant movement due
to their thermal energy of the order of kBT . The diffusion coefficient for the particles is
given by the Stokes-Einstein equation∗:
D =
kBT
6piηr
(3.16)
where η is the dynamic viscosity of the medium and r the hydrodynamic radius of the
particle. As can be seen from this equation, the diffusion coefficient of the particle is directly
related to its size. Measuring the diffusion coefficients of particles undergoing Brownian
motion thus makes it possible to calculate their size distribution. Several techniques take
advantage of this principle to determine the size distribution of nanoparticles in solution.
One example is nanoparticle tracking analysis (NTA) [75].
In single particle tracking (SPT) the trajectories of individual particles are analyzed to
extract information about diffusivity and type of motional behavior. This technique is
often used in combination with fluorescence microscopy and based on the fact that the
position of single fluorescent objects can be determined with a localization precision in
the nanometer range, by applying a Gaussian fit to their intensity profiles [76]. SPT has
been very popular to study the mobility of lipids and proteins in cell membranes, being an
alternative to widely used ensemble averaging techniques, like fluorescence recovery after
photobleaching (FRAP) for example†. A common approach in SPT analyses is to calculate
the mean squared displacement (MSD) of the tracked particles. The MSD is a measure
of the deviation of the particle position in relation to a reference position over time. It is
defined as:
MSD(∆t) = 〈(xi+n − xi)2 + (yi+n − yi)2〉 (3.17)
for n = 1, 2, 3, . . . , N . The particle located in (xi, yi) will be at position (xi+n, yi+n)
after n frames. ∆t = nτ is called lag-time, where τ is the time between frames. N is an
arbitrary number, but should in general be chosen smaller than one quarter of the total
frame number to avoid falsification of MSD values at high lag-times due to too few data
points [15]. An illustration of how the MSD is determined for a particle trajectory is shown
in figure 3.4a.
For a particle performing a random walk in a two-dimensional plane the MSD curve is
linear:
MSD(∆t) = 4D∆t (3.18)
∗The Stokes-Einstein equation is valid for fluids of low Reynolds number.
†In a FRAP experiment, a small region of a fluorescent sample is photobleached to measure the diffusion
of molecules in and out of the bleached spot [77–79].
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We then talk about normal diffusion and the diffusion coefficient is estimated from a linear
fit of the MSD curve. Equation (3.18) can be generalized to account for anomalous diffusion,
the case when the normal diffusion of the particle is hindered:
MSD(∆t) = 4D∆tα (3.19)
where α = 1 for normal diffusion and α < 1 for anomalous diffusion.
For confined diffusion we observe an asymptotic MSD curve:
MSD(∆t) = Ac
[
1− C1 exp
(
−4C2D∆t
Ac
)]
(3.20)
Ac is the area of the confinement and the constants C1 and C2 are given by the geometry
of the confinement. Finally, the MSD for diffusion under directed motion is given by:
MSD(∆t) = ν2∆t2 + 4D∆t (3.21)
where ν is the velocity of the directed motion. Figure 3.4b illustrates how the MSD curve
is interpreted to classify the trajectories into the different types of diffusion.
∆t = τ ∆t = 4τ∆t = 3τ∆t = 2τ
τ 2τ 3τ 4τ
Lag-time ∆t 
MSD (∆t)  
(a)
M
S
D
 
Lag-time ∆t  
Normal Diffusion 
Anomalous Diffusion 
Confined Diffusion 
Active Transport 
MSD (∆t)  
Lag-time (∆t)  
Normal diffusion
Anomalous diffusion
Confined diffusion
Active transport
(b)
Figure 3.4: Mean squared displacement (MSD), inspired from [80]. (a) Illustration of how
an MSD curve is obtained for an arbitrary trajectory and ∆t = τ, 2τ, 3τ, 4τ . (b) Different
modes of diffusion (active transport, normal diffusion, anomalous diffusion, and confined dif-
fusion) can be determined by the behavior of the MSD curve (see main text for corresponding
equations).
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4Strategies for probing virus-cell
membrane interactions
“Everything should be made as simple as possible, but not simpler.” – Albert Einstein
During the infection cycle, viruses encounter the cell membrane at multiple occasions. As
described more in detail in chapter 2, an infection is initiated by the attachment of the
virus to the cell membrane, and, for many types of infections, concludes with the release
of progeny virus from the cell membrane. Therefore, the interactions occurring between
viral binding proteins and cell membrane components play a key role during infection
and are subject to a lot of attention in virus research. These efforts aim to develop a
fundamental knowledge of virus-cell membrane interactions, with the ultimate goal to
identify new antiviral compounds (targeting either viral or cellular binding molecules) that
inhibit initial binding to the cell membrane or the release of progeny virus from the cell
membrane.
This chapter reviews commonly used strategies to study virus-cell membrane interactions.
The main focus of this chapter will be on surface-based methods, which recognize binding
events between two entities of which one is attached to a surface. Such assays offer the
possibility to focus exclusively on binding events between the virus (or viral binding pro-
teins) and cell membrane components, without the contribution of other cellular factors.
The complexity of the presented systems increases throughout the chapter, starting off
with very simple systems involving only the two binding entities of interest, and moving
towards complex native systems. Finally, a short section will be dedicated to solution-
based systems, which do not require the presence of a surface for recognition of binding
events.
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4.1 From surface-immobilization of membrane recep-
tors to artificial cell membrane mimics
Initial binding of viruses to the cell membrane occurs between specific viral binding pro-
teins and cellular attachment factors and is followed by viral entry, which requires a strong
attachment of the virus to so-called entry receptors. To characterize these specific inter-
actions, a number of strategies have been developed to isolate the viral binding protein
and cell membrane component of interest and measure their interaction kinetics using
surface-based sensing. The most common approach of such methods is to attach the cell
membrane component (herein called receptor) to the sensor surface (figure 4.1) and to add
the viral protein (herein called ligand) to the solution that the surface is exposed to. This
simple strategy has been used, for example, to extract information about binding kinetics
for biomolecular interactions between viral glycoproteins and cell membrane attachment
factors [81;82]. These receptor-based systems represent the most simplified approach to mea-
sure virus-cell membrane interactions. They make it possible to isolate the interaction
of interest from other cellular processes occurring in vivo, and present a high degree of
control and flexibility. For example, receptor density and physicochemical properties of
the surface can easily be tuned to meet the needs of the experimenter. Furthermore, these
systems are well-suited for inhibition studies that aim at testing new antiviral compounds
targeting specific cell membrane or viral components [83;84]. A major challenge when work-
ing with receptor-based systems arises from the need to extract the membrane components
of interest from their native environment, where they are usually present at very low lev-
els. Common methods to purify membrane protein receptors, for example, rely on genetic
overexpression [85] and detergent solubilization methods [86;87]. Receptor immobilization can
be achieved in many different ways, mainly depending on the physicochemical properties
of the substrate and the biomolecule to be immobilized. Common strategies include di-
rect adsorption, covalent binding through amino groups, and affinity interactions between
recognition pairs (i.e. biotin-avidin) [88;89]. Another challenge for these systems in particu-
lar, and surface-based methods in general, are non-specific interactions of ligands with the
surface. Various surface passivation strategies have been developed to coat the surface with
non-reactive compounds, thereby reducing levels of non-specific ligand adsorption. Which
passivation agent to use usually depends on the type of substrate. Standard examples
are Poly(L-lysine)-g-Poly(ethylene glycol) (PLL-g-PEG) or bovine serum albumin (BSA)
coatings [90;91].
The simplicity of the above-described receptor-based systems, which offers advantages in
terms of flexibility and control, also represents a major limitation. For example, it has
been shown that certain cell membrane receptors, in particular membrane proteins, re-
quire their natural lipid environment to preserve their functionality [92;93]. Furthermore,
certain viruses could rely on membrane receptor mobility to engage in multivalent inter-
actions [94], which would be an important factor for studies involving whole virus particles.
For this reason, many studies incorporate the purified membrane receptors in so-called
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supported lipid bilayers (SLBs) (figure 4.1). SLBs are planar double-layered sheets of
lipids formed on a support. SLBs can form spontaneously from lipid vesicles, which are
spherical shells made of a lipid bilayer. When put in contact with the substrate, vesicles
adsorb to it and, upon reaching a critical surface coverage, rupture to form an SLB [95;96].
This approach is one of the simplest to create SLBs. Another common method to form
SLBs are deposition methods like the Langmuir-Blodgett method for example, which forms
lipid films in a layer-by-layer approach by immersing the substrate into an aqueous solu-
tion exposing the lipid molecules at the air-solution interface [97]. The choice of substrate
is critical for successful SLB formation. Indeed, spontaneous SLB formation via vesicle
rupture has been shown for a limited number of materials only (mostly glass and other
silica substrates [98]), and requires thorough cleaning procedures, which can challenge the
reproducibility of SLB-based studies. SLBs represent two-dimensional fluids, in which the
lipid molecules can diffuse freely. Therefore, a major advantage of these systems over
simpler receptor immobilization-based systems is that the mobility of the incorporated
membrane receptors can be preserved. Hence, SLB-based systems represent models of the
cell membrane that are closer to the native cell membrane, while preserving the control
and flexibility of the direct surface-immobilization approach. Furthermore, lipid bilayers
have been shown to serve as a passivation layer, reducing non-specific interactions with the
substrate [99]. SLB-based systems have been used, for example, to gain important insights
into the kinetics and diffusion properties of virus-cell membrane interactions [64;66;100;101], as
well as to study viral fusion [102;103].
Complexity
Receptor-based platform SLB-based platform nSLB-based platform
Figure 4.1: Illustrations of three surface-based platforms to probe virus-cell membrane in-
teractions described in this chapter. The first one is based on the immobilization of cell
membrane receptors of interest to a sensing surface. In the second one the membrane recep-
tors are embedded in a supported-lipid bilayer. In the third one SLBs are formed directly from
native cell membrane material.
4.2 Supported lipid bilayers from native cell mem-
brane material
The previous section dealt with artificial systems commonly used to probe virus-cell mem-
brane interactions, starting off with very simplified receptor-based systems and introducing
SLBs as a means to better mimic the structure of the cell membrane and preserve protein
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functionality and mobility. These SLBs can be tuned to increase in complexity, by incor-
porating, for example, different types of lipids, membrane proteins or other cell membrane
molecules, such as cholesterol [104;105]. This approach of gradually increasing the complexity
of the system can be viewed as a bottom-up design. As an alternative, using a top-down
design, one starts from a very complex system and simplifies it to meet the needs of the
experimental setup. In particular in this context, a top-down approach would be to form
SLBs directly from native cell membrane material (figure 4.1). As compared to artificial
SLBs, the composition of such native-like SLBs (nSLBs) is closer to native cell membranes,
as they contain the whole range of membrane components (e.g. lipids, proteins, carbohy-
drates), without relying on detergent-based purification methods. nSLB systems fill the
gap between simplified artificial systems and complex live-cell experiments: a combination
of high compositional complexity and flexibility, compatible with surface-based methods,
which isolates the membrane-related processes from other cellular factors.
Different methods can be used to extract native cell membrane material from cells and
obtain so-called native membrane vesicles (NMVs). Two common methods are mechanical
cell disruption and centrifugation [106;107], and cell blebbing [108;109]. While these extraction
procedures can already bring about certain complications, the main challenge of nSLB-
based systems lies in the formation of SLBs from NMVs, which contain high amounts of
proteins, gel-phase lipids, and cholesterol, which have all been shown to impair spontaneous
vesicle rupture [104;105;110;111]. A number of strategies have been developed to overcome
this issue [112], including bilayer edge-induced vesicle fusion [113], α-helical (AH) peptide-
induced vesicle fusion [105], co-adsorption of synthetic and native vesicles [109;114], formation
of hybrid vesicles via sonication of synthetic and native vesicles [115], as well as the use of
polyelectrolyte cushions to facilitate vesicle rupture [116].
To this day, only very few studies have used nSLB systems to probe virus-cell membrane
interactions [117]. In paper V we implemented a platform based on the hybrid vesicle
method [118] to measure binding kinetics and diffusion of single HSV-1 particles.
4.3 Viral cell-based assays
As stated above, the different systems presented in this chapter follow a trend of increasing
complexity. For this reason, this section is dedicated to commonly used assays that involve
whole cells, thereby offering the full range of cellular and viral factors to probe virus-cell
membrane interactions. As we will discuss, the trade-off is a loss in control and flexibility
as provided by the above described model systems. The assays described herein are of
relevance to this thesis work and only represent a small fraction of the numerous cell-based
assays used in virus research.
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4.3.1 Viral plaque assay
A commonly used assay in virus research is the viral plaque assay [119;120]. It is used mainly
to measure the infectivity of a virus suspension and determine the infectious dose. Such a
plaque assay consists of preparing a dilution series (usually 10x-fold dilutions) of the virus
suspension and incubating a confluent dense monolayer of cells with the virus solution
of a given dilution factor. Infected cells will produce new progeny virus and undergo
morphological changes (for example due to cell lysis). To restrict the spread of the infection
to neighboring cells only, a gel-like substance is usually added to the cell medium. A plaque
will form at the infected area, which grows in size and, after a few days typically, becomes
visible to the naked eye (figure 4.2). With a simple manual readout scheme, one then
determines the number of plaque forming units (PFU) per milliliter of the initial virus
suspension. Since the PFU count is a measure of the infectivity of the virus suspension,
the viral plaque assay is a common method for testing anti-viral compounds. It is very
versatile with respect to which step of the virus infection cycle the given compound targets,
and has been used, for example, to evaluate the efficiency of binding inhibitors [121;122], i.e.
compounds which prevent the virus from binding to the cell membrane. However, this
assay does not isolate initial binding from the other steps of the viral infection cycle, like
the assays based on cell membrane mimics described above did. Therefore it is not possible
to distinguish between an impaired ability of the viruses to bind to the cell membrane, or,
for example, to replicate within the cell.
104 × 105 × 106 ×
107 × 108 × 109 ×
Figure 4.2: Illustration of the viral plaque assay. Virus solutions of different dilution factors
are added to a monolayer of cells to determine the level of infectivity of the viral suspension
by counting the number of plaque forming units (PFU).
4.3.2 Single-cell imaging
Single-cell imaging denotes a collection of microscopy techniques allowing the acquisition
of images from individual cells. Examples of such microscopy techniques are electron mi-
croscopy and fluorescence microscopy. In virus research, such techniques can be used to
observe, track and count viral particles engaging with the imaged cell. This is usually
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achieved by attaching a fluorescent probe to the viral particle. In electron microscopy, a
technique that was used in paper II & IV, the resolution of the images is high enough to
detect single virus particles, and image their structure (figure 2.5b). Therefore the tech-
nique is well-suited to, for example, count the number of virions at the cell surface, which
in paper II & IV allowed us to gain insights into the ability of certain HSV variants to
release from the surface of the infected cell. However, electron microscopy is not compat-
ible with live cells. For this reason, the infected cells are fixated prior to imaging, which
does not make it possible to study dynamic processes.
To study the dynamic processes occurring on the cell surface during initial attachment,
and prior to cell uptake, fluorescence microscopy techniques, such as total internal reflec-
tion fluorescence microscopy (introduced in chapter 5) or scanning confocal microscopy
are commonly used [80;123], although studies using label-free techniques based on scatter-
ing have also been reported [124]. These high-resolution microscopy techniques are used in
combination with single particle tracking to characterize the diffusive behavior of viruses
on the cell surface, and inside the cell. In particular, live-cell SPT has been used for the
observation and characterization of lateral mobility along the cell surface for a number
of viruses, such as dengue virus [125;126], sindbis virus [127], influenza A [128], adenovirus type
2 [129], murine polyomavirus [130] (study on virus-like particles), vaccinia virus [124], as well as
bacteriophage lambda [68]. The biological significance of these observations will be further
discussed in chapter 7. As compared to SPT studies on planar membrane systems, addi-
tional efforts are usually needed in live cell imaging to discern virus particles diffusing on
the cell membrane from the ones in solution or within the cell. Also, the inherent movement
of the cells can complicate the tracking analysis.
4.4 Solution-based assays
Most of the systems that were described in this chapter are surface-based. However, al-
though not further explored in this thesis work, solution-based systems offer an alternative
method to probe virus-cell membrane interactions without relying on the attachment of
the studied membrane receptor to a sensor surface. This has the advantage of circum-
venting the difficulties related to non-specific surface interactions and to mimic a reaction
environment that is more similar to the in vivo environment, where interaction partners
are rarely static. Solution-based assays to probe virus-cell membrane interactions often
rely on ensemble averaging, which means that they do not resolve single binding events
but measure signals that originate from a collective of binding events. Such assays have for
example been used to study fusion of enveloped viruses with liposomes [131;132]. Neverthe-
less, solution-based systems can also be combined with single particle approaches, as has
been done, for example, to detect virus particles in solution [133].
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“I suppose it is tempting, if the only tool you have is a hammer, to treat everything as if it
were a nail.” – Abraham Maslow
Experimental strategies to probe virus-cell membrane interactions rely on two key elements.
The first one is the biological system, which can either be a model of the cell membrane
characterized by a certain level of compositional complexity, or whole cells in the case of
cell-based assays, as discussed in the previous chapter. In this chapter we focus on the
other key element, which is the experimental technique used to detect and characterize the
biomolecular interactions between the virus (or viral glycoproteins) and the cell membrane.
The main technique used in the context of this thesis to probe the interactions between HSV
and cell membrane mimics is total internal reflection fluorescence microscopy (TIRFM),
which is a surface-sensitive microscopy technique relying on the fluorescent labeling of
the studied sample. In addition, we used atomic force microscopy (AFM), and surface
plasmon resonance (SPR), which also both recognize biomolecular interactions occurring
at a surface. TIRFM and AFM can both be used for single-particle studies, as they
allow the recognition of single binding events. This is a major advantage when studying
highly heterogeneous virus samples, which can contain subpopulations with very distinct
physicochemical properties. SPR on the other hand is an ensemble averaging technique,
measuring collective binding events. In this work, SPR was used for characterization
of the model surfaces, and to measure binding kinetics of viral glycoproteins to GAGs.
The theoretical background of these three techniques will be provided in this chapter. In
addition, the concept of fluorescence will be introduced, together with Fo¨rster resonance
energy transfer (FRET), a method used in this thesis to monitor vesicle fusion.
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5.1 Surface plasmon resonance (SPR)
Surface plasmon resonance (SPR) is a widely used technique in biosensing applications. It
was introduced in the early 1980s when Liedberg et al. demonstrated its potential for gas
detection and antibody adsorption [134]. Today SPR is a very popular technique to study
protein-ligand interactions, in particular in the context of drug development [135]. It allows
the monitoring in real-time of the refractive index change caused by adsorbing molecules
to a sensor surface, making it possible to extract information about binding kinetics and
affinity of biomolecular interactions.
SPR takes advantage of surface plasmons, which are collective oscillations of free electrons
of a metal, arising at the interface between the metal and a dielectric medium when excited
by light under certain conditions. The electromagnetic waves coupled to this oscillation
are called surface plasmon polaritons. They propagate along the interface and generate
an evanescent field on both sides of the interface [136]. The dispersion relation of this two-
dimensional waves is given by [137]:
ksp =
ω
c
(
1

+
1
m
)−1/2
(5.1)
where ω is the angular frequency, c the speed of light, m the real part of the dielectric
constant of the metal at the given frequency, and  the dielectric constant of the second
medium. Given the nature of the two media, we have m < 0,  > 0 and |m|  ||.
Equation (5.1) can be simplified to:
ksp =
ω
c
√
 =
ω
c
n (5.2)
with n being the refractive index of the dielectric medium. If we consider an incident light
beam impinging under an angle Θ on the interface, the parallel component of the wave
vector is given by:
kx =
ω
c
√
 sinΘ (5.3)
Excitation of surface plasmons requires phase matching of the wave vectors ksp and kx
[136].
As can be seen from equations (5.2) and (5.3), this is impossible since kx is always smaller
than ksp. To obtain phase matching a different geometry has to be used. If we instead con-
sider a three-layer system, consisting of a thin metal film sandwiched between two insulation
media of different dielectric constants a and g, equations (5.2) and (5.3) become:
ksp =
ω
c
√
a =
ω
c
na (5.4)
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kx =
ω
c
√
g sin Θ =
ω
c
ng sin Θ (5.5)
Thus making the solution ksp = kx possible if ng > na.
The most commonly used configuration to achieve surface plasmon excitation in SPR is the
Kretschmann configuration [138]. It consists of a glass prism coated with a thin (∼ 50 nm)
metallic film, usually made of gold (figure 5.1). The light beam hits the interface of the
metallic film with an angle higher than the critical angle of total internal reflection (see
section about TIRFM for the theory about total internal reflection). When resonance
is achieved, the surface plasmons will be excited at the interface between the metal and
the ambient medium (usually water). The evanescent field generated by the surface plas-
mon resonance along the z-axis penetrates the ambient medium by a couple of hundred
nanometers, thus making SPR a surface sensitive technique.
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Figure 5.1: Working principle of SPR using the Kretschmann configuration. A thin metal
film coated onto the backside of a glass prism is illuminated with a laser beam in total internal
reflection. At a certain angle, surface plasmon resonance is achieved and an evanescent field is
created at the metal-solution interface. A change in refractive index upon binding of molecules
to the surface will result in a change of resonance angle.
The main working principle of SPR is that when molecules adsorb to the metal/water
interface, the refractive index of the ambient medium na will change and resonance will
occur at a different angle Θ, according to equations (5.4) and (5.5):
ksp = kx ↔ Θ = arcsin
(
na
ng
)
(5.6)
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SPR therefore senses small changes in refractive index due to molecular adsorption at the
interface causing a shift of the angle at which resonance is obtained. The surface coverage
(adsorbed mass per unit area) can be related to the refractive index change ∆n, and the
difference in resonance angle ∆deg using [139;140]:
∆Γ =
d∆n
(dn/dC)
=
d
S(dn/dC)[1− exp(−d/δ)]∆deg (5.7)
In expression (5.7), d is the film thickness, S the sensitivity of the instrument expressed
in degrees per refractive index unit, (dn/dC) the refractive index increment per biomolecule
concentration in solution and δ the decay length of the intensity of the evanescent field.
5.2 Fluorescence and Fo¨rster resonance energy trans-
fer (FRET)
Fluorescence is the emission of light by a molecule, called fluorophore, excited by incident
light of a certain wavelength. The fluorophore, initially in the ground energy state S0,
absorbs the energy of the incoming photon to reach the next higher energy state S1. The
energy of the photon must correspond to the energy gap between the two states and
typically lies in the visible light spectrum. S1 being an unstable energy state, the molecule
then returns to the ground state via a relaxation process. This relaxation is divided into a
vibrational relaxation process and a radiative relaxation process, emitting a photon of lower
energy (longer wavelength) than the excitation photon. Figure 5.2 illustrates this process
with a Jablonski diagram. The typical lifetime of fluorescence, defined as the average time
between excitation and return to the ground state, is around 10 ns [141].
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Figure 5.2: Jablonski diagram illustrating the principle of fluorescence. A fluorophore in the
ground state S0 is excited to the higher energy state S1 upon absorption of the energy of an
incoming photon. During relaxation a photon of longer wavelength (lower energy) is emitted.
Fluorescence is widely used to image biological samples. The main reason for this is that
submicrometer-sized objects interact poorly with ambient light and are therefore hardly
34
CHAPTER 5. EXPERIMENTAL METHODS
visible in a regular optical microscope. However, thanks to the use of fluorescence, those
objects can become visible in a fluorescence microscope. Certain molecules or proteins can
be naturally fluorescent (such as the green fluorescent protein (GFP), for example). Alter-
natively, biomolecules can be fluorescently labeled, by attaching fluorophores via specific
functional groups. In this work, we used a membrane-inserting dye to fluorescently label
the viral envelope of the HSV particles.
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Figure 5.3: Jablonski diagram illustrating the process of Fo¨rster resonance energy transfer
(FRET). The energy of the excited fluorophore (donor) is transferred to another fluorophore
(acceptor) through a non-radiative process, if the excitation spectrum of the acceptor overlaps
with the emission spectrum of the donor. Upon relaxation, the acceptor emits a photon of
longer wavelength (lower energy).
Another possible outcome for a fluorophore in the excited energy state, is an energy transfer
via a process called Fo¨rster resonance energy transfer (FRET) [142]. FRET occurs when the
emission spectrum of one fluorophore (the donor) overlaps with the excitation spectrum of
another fluorophore (the acceptor). This process, illustrated in figure 5.3, is a result of a
dipole-dipole interaction between the two fluorophores, which makes it a non-radiative en-
ergy transfer (there is no intermediate photon). The FRET efficiency E, strongly depends
on the intermolecular distance r of donor and acceptor [141]:
E =
1
1 + (r/R0)6
(5.8)
R0 is the distance between donor and acceptor at which the energy transfer is 50%, also
called Fo¨rster distance, given (in A˚) by [141]:
R0 = 9.78× 103 6
√
κ2QD
n4
J(λ) (5.9)
where κ2 describes the relative orientation between the dipoles of donor and acceptor, QD
is the quantum yield (number of emitted photons over number of absorbed photons), n is
the refractive index of the medium, and J(λ) describes the spectral overlap between donor
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emission and acceptor excitation (in M−1cm3). R0 is typically in the range of 30 to 60
A˚ [141]. Because of the strong dependency of the FRET efficiency on the distance between
the two fluorophores, FRET serves as a useful method to estimate intermolecular distances
in the nanometer range. For example, FRET assays have been used to detect biomolecular
interactions, such as protein-protein interactions [143], to study protein folding [144], and to
monitor vesicle fusion [145]. In paper V, we used a FRET assay to estimate the mixing
efficiency of synthetic vesicles with native membrane vesicles, as well as to quantify these
native membrane vesicle suspensions.
5.3 Total internal reflection fluorescence microscopy
(TIRFM)
Total internal reflection fluorescence microscopy (TIRFM) is a technique combining three
key elements: microscopy, fluorescence and total internal reflection. All of these elements
had been widely used independently before Daniel Axelrod combined them to image cell
structures in contact with a solid substrate in the early 1980s [146]. The full theory behind
the technique was described three years later [147]. Since then, TIRFM has been used for a
wide range of applications, many of them of biological nature.
TIRFM is primarily a fluorescence microscopy technique. It takes advantage of the discrep-
ancy between fluorescence excitation and emission wavelengths (see figure 5.2) to simul-
taneously activate and detect the signal of fluorescent probes. A common TIRFM setup
(figure 5.5) uses a white light source in combination with an excitation filter, selecting a
range of wavelengths that overlaps with the excitation spectrum of the fluorophore in the
sample, and an emission filter, to allow only light originating from the fluorescent probe to
reach the camera. Alternatively, laser setups can be used instead of the white light source
to illuminate the sample.
The element that distinguishes TIRFM from regular fluorescence microscopy is the total
internal reflection (TIR) setup. To explain the principle of TIR one uses geometrical optics.
Snell’s law describes how a light beam behaves when impinging on an interface of two media
with different refractive indexes n1 and n2:
n1 sin Θ1 = n2 sin Θ2 (5.10)
Θ1 and Θ2 are the angle of incidence and angle of refraction, respectively. This formula
shows how the angle of refraction depends on the angle of incidence and the refractive
indexes of the two media. If the second medium is of lower refractive index (n2 < n1), the
refracted beam will travel along the interface of the two media at Θ1 = Θc. This angle,
called critical angle, is given by:
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Θc = arcsin
(
n2
n1
)
(5.11)
For angles equal to or greater than the critical angle (Θ1 ≥ Θc) the incident beam is totally
reflected at the interface. This situation is called total internal reflection and represented
schematically in figure 5.4.
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Figure 5.4: Illustration of Snell’s law and the principle of total internal reflection. For
incident angles equal to or greater than a critical angle Θc, the incident beam is totally
reflected at the interface with a lower refractive index medium.
An evanescent field is then created at the interface, extending a small distance into the
optically thinner medium. The intensity I of this evanescent field at a distance z from the
interface is given by [148]:
I(z) = I0 exp
(−z
d
)
(5.12)
I0 is the intensity at the interface and the characteristic exponential decay depth d is
defined as:
d =
λ
4pin2
(
sin2 Θ1
sin2 Θc
− 1
)−1/2
(5.13)
with λ denoting the wavelength of the incident light.
The exponential decay depth d is usually on the order of the wavelength λ or smaller,
meaning that only fluorescent molecules within a couple of hundred nanometers away from
the surface will be excited by the incident light, while particles in the bulk solution remain
invisible. This principle makes TIRFM a surface sensitive technique, well-suited to be used
in combination with surface-based assays, like the ones presented in chapter 4.
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Figure 5.5: Working principle of TIRFM including the three main key elements: fluores-
cence, optical microscopy and total internal reflection. An excitation filter selects an appropri-
ate range of wavelengths from a white light source to excite the fluorescent probes. A dichroic
mirror is used to direct the light to the objective, whose crescent-shaped aperture generates
total internal reflection of the incident light. The fluorescent light emitted from the sample
passes an emission filter (that sorts out the excitation light) and is collected by a camera.
5.4 Atomic force microscopy (AFM)
The atomic force microscope (AFM) was invented by Gerd Binnig, who patented the
technique and, together with Calvin F. Quate and Christoph Gerber, published its first
experimental implementation [149] in 1986. Binnig was also one of the inventors of the
precursor technique, the scanning tunneling microscope (STM), for which he was awarded
the Nobel Prize in Physics in 1986, together with Heinrich Rohrer [150]. Both techniques
were developed to image surfaces with atomic resolution by scanning the sample with a
mechanical probe, which is brought into very close proximity to the surface. In STM a
voltage is applied between the conducting probe and the sample, leading to a transfer of
electrons, called tunneling current. During an x-y scan, the probe is moved across the
sample to measure the tunneling current for each position and determine, amongst others,
the topography of the surface. While STM relies on the conductive properties of the sample,
an AFM directly measures the force exerted by the surface onto the probe and can therefore
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be applied to the study of both conductors and insulators. Thanks to the possibility of
using the instrument in different media such as vacuum, air, but also liquid environments,
AFM has, since its first commercial appearance in 1989, been used for a wide range of
applications. One field of application that has considerably increased in popularity in the
past decade is cell biology and microbiology, as the AFM has proven itself to be a powerful
tool for probing biological samples, such as living cells and bacteria [151;152], proteins [153–155],
viruses [156–158], and DNA [159;160].
The basic working principle of a typical AFM instrument is shown in figure 5.6. The
scanning probe, usually denoted AFM tip, is attached to a spring-like cantilever. When
the tip is approached to the surface the force emerging between surface and tip will cause
a deflection of the cantilever’s free end. This deflection distance is usually measured using
an optical system, consisting of a laser beam that is reflected on the apex of the cantilever
and whose signal is collected by a photodiode. To perform a scan of the surface, either the
cantilever or the sample is coupled to a piezoelectric element, which deforms when exposed
to a voltage, thereby allowing very small and accurate displacements.
Cantilever
Laser beam
Piezoelectric
scanner
Photodiode
Sample
Tip
Figure 5.6: Schematic representation of a typical AFM. A probe, usually called AFM tip,
is attached to a cantilever and approached to the sample surface. The deflection of the can-
tilever upon interaction between tip and surface is measured using an optical readout system
consisting of a laser beam and a photodiode. To perform a scan of the sample surface, a
piezoelectric scanner is used.
Since its introduction, the AFM has become a well-established tool for topographic imag-
ing. But besides imaging, the AFM is also increasingly used for force spectroscopy, due
to its ability to directly measure the tip-sample interactions and to generate force-distance
(FD) curves [161]. This, together with the possibility of functionalizing the AFM tip with
biomolecules of interest [162], has opened up the way for FD-based AFM to become a valu-
able tool to study ligand-receptor interactions [153;163–165]. Typically, the molecule of interest
is attached to the AFM tip via a polymeric linker and the cantilever performs sequential
approach and retraction cycles (figure 5.7a), during which the cantilever deflection is mon-
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itored. From the measured cantilever deflection δc, one can calculate the force F , using
Hooke’s law [161]:
F = −κs δc (5.14)
The constant κs denotes the effective spring constant of the system, determined by the
spring constant of the cantilever and the elastic constants describing the tip functionaliza-
tion complex and the sample deformation. The measured force can be expressed in terms
of tip-sample distance D = z−δc, with z denoting the controlled distance, i.e. the distance
at rest between cantilever and surface:
F (D) = −κs (z −D) (5.15)
Equation (5.15) shows the relation between measured force and tip-sample distance, which
is represented in the FD curve (figure 5.7b). One usually draws both the approach and
retraction curve, from which one can extract information about, for example, the sample
thickness, deformation, and elasticity. From the retraction curve one also extracts the
adhesion force that, upon contact, emerges between the ligand on the functionalized AFM
tip and the receptor molecule in the sample.
As predicted by the Bell-Evans theory [166–169], the measured bond rupture force of the
ligand-receptor pair depends on the applied loading rate (rf ) in N/s, which is defined
as [168]:
rf = κsvpull (5.16)
where vpull is the pulling velocity (derivative of the tip oscillation
[170]). In a typical force
spectroscopy experiment, rf is not constant, as the applied force is usually increased until
bond rupture is achieved. rf can then be calculated from the slope of the force-time curve
directly prior to the bond rupture event [170] (figure 5.7a).
To conceptualize the dependence of measured adhesion force on loading rate, it is useful
to visualize the free energy landscape of a bond (figure 5.7c), which, in particular for
weak noncovalent bonds governing biomolecular interactions, is fully explored by thermal
fluctuations [167]. In this free energy landscape, the bond is represented as a local minimum
energy state, characterized by a sharp energy barrier Eb that needs to be overcome to break
the bond. The likelihood of reaching the transition state (i.e. bond breakage) is given by
the dissociation rate constant:
koff ∼ exp
(−Eb
kBT
)
(5.17)
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which also determines the lifetime of the bond:
toff =
1
koff
(5.18)
When applying an external pulling force (FL) to the system, the time of survival of the
bond is decreased, which can be represented by a lowering of the energy barrier Eb in the
energy landscape [169]. As a consequence, the off rate of the bond is increased by a factor
exp(−FL/Fβ), where
Fβ =
kBT
xβ
(5.19)
xβ represents the reaction coordinate at the transition state. Thus, if a fast loading rate is
applied (high applied force over time), the bond will have a short lifetime, but withstand
large forces, since the likelihood of stochastic bond rupture through thermal activation is
low. From the Bell-Evans theory it follows that the most frequently observed rupture force
F ∗ shows a linear behavior when plotted against the logarithm of the applied loading rate
rf (figure 5.7d). This relationship is written as follows
[169]:
F ∗ = Fβ loge
(
rf
koffFβ
)
(5.20)
Equation (5.20) can be used to extract the dissociation rate constant koff for the studied
bond, as well as the reaction coordinate xβ. In case of multiple bonds, the energy landscape
can become more complex, e.g. showing a cascade of energy barriers, each characterized
by their individual energy barrier height Eb and width xβ. Plotting rupture force F
∗
against the logarithm of the applied loading rate rf will give rise to multiple linear regimes,
corresponding to the individual bonds [167], from which one can extract koff and xβ values
for each bond.
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Figure 5.7: Force-distance based AFM. (a) The cantilever is oscillated at a set frequency,
performing cycles of approach and retraction. From the cantilever deflection, one calculates
the force F using Hooke’s law. The force-time curve is used to extract the loading rates (rf ;
slope of the curve directly prior to the bond rupture event) (b) Force-distance curves are used
to determine the adhesion force between the functionalized tip and the surface. (c) Applying
a mechanical pulling force to the system changes the energy landscape of the bond towards
lower dissociation energy barriers. (d) The force follows a linear relationship with regards
to the logarithm of the loading rate. The slope of the linear curve is given by Fβ =
kBT
xβ
,
where xβ represents the reaction coordinate at the transition state. For multiband reactions,
different linear regimes will appear.
42
6Results
“Research is formalized curiosity. It is poking and prying with a purpose.”
– Zora Neale Hurston
This thesis focuses on the interactions between HSV and the cell membrane during initial
attachment and release. Using traditional cell-based assays, the main actors of these pro-
cesses have been identified to be viral glycoproteins gC and gB, and cell-surface GAGs.
In order to gain further insights into the dynamic mechanisms regulating attachment and
release, and to probe HSV-cell membrane interactions on a molecular level, our strategy
was to complement cell-based assays with bioanalytical model platforms, designed to mimic
the architecture of the native cell membrane. The advantage of such model platforms is
twofold: First, they allow us to isolate the interactions occurring at the membrane from
other cellular processes; second, they are compatible with surface-based sensing methods,
allowing for high sensitivity interaction studies, down to the single particle level, which is
an advantage, for example, when working with samples of high heterogeneity.
Two cell membrane mimics were implemented in this work. The first one was based on end-
grafted GAG chains, allowing us to focus solely on the HSV-GAG interactions. The second
one was derived from native cell membranes, to include the whole milieu of cell membrane
receptors, and probe HSV binding characteristics in a more native-like environment. These
model platforms, introduced in the first section of this chapter, were used in combination
with SPR, TIRFM, and FD-based AFM to measure binding kinetics, particle mobility, and
binding forces. Two factors likely to influence the characteristics of the HSV-cell membrane
interactions were investigated. The first one was the physicochemical properties of the
GAGs, discussed in paper I. Paper II-IV focus on the role of the viral glycoproteins, and
in particular their glycosylation, in regulating attachment and release of HSV-1 (paper II
& III) and HSV-2 (paper IV).
This chapter provides a summary of the main aims and findings of the appended papers.
For an in-depth discussion of the results, and experimental details, the reader is referred
to the respective paper.
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6.1 Bioanalytical platforms to probe HSV-cell mem-
brane interactions
Because of their essential role during initial HSV attachment, the HSV-GAG interactions
are the main focus of this work. To be able to study these interactions in a controlled way,
we implemented a platform (herein called GAG platform), which mimics the presentation
of GAGs in the extracellular matrix and at the cell surface. The GAG chains were end-
grafted to a sensor surface, thereby creating a brush-like architecture, which resembles the
natural attachment of GAGs to proteoglycans. The platform is based on a planar SLB
(or self-assembled monolayer in paper II), providing surface passivation, and a support to
attach the GAG chains using biotin/streptavidin coupling [171;172] (illustrated in figure 6.1a).
The surface functionalization was monitored in real-time using surface plasmon resonance
(SPR) to determine the surface densities of the end-grafted GAGs (paper I).
The GAGs used in this work were chondroitin sulfate (CS), heparan sulfate (HS), hyaluronic
acid (HA), and sulfated hyaluronic acid (sHA). CS and HS are native GAGs, known to
interact with HSV-1 and HSV-2 [7;46]. These molecules are sulfated through enzymatic
action, which confers a high degree of heterogeneity to their sulfation patterns. In contrast,
sHA originates from chemically sulfated HA chains, and therefore most likely presents a
more homogeneous distribution of sulfate groups. sHA was used, for example, in paper I
to study the importance of the native arrangement of sulfate groups along the GAG chain.
HA is the only GAG that is not sulfated and was therefore used as a negative control to
test the specificity of HSV binding to sulfated GAGs.
The GAG platform was used in paper I - IV, in combination with SPR, to measure
binding kinetics of purified gC glycoproteins to GAGs (CS and sHA), TIRFM to measure
binding kinetics and lateral diffusion of entire HSV virions, and FD-based AFM to measure
binding forces of the HSV-GAG interaction.
To complement our GAG platform, we were interested in a second platform, of higher com-
positional complexity, to create a more native-like interaction environment that includes
all cellular membrane receptors. We opted for a top down approach, namely nSLBs derived
from native cell membrane material (introduced in chapter 4), which offer high composi-
tional complexity, compatible with surface-based methods (figure 6.1b). In particular, we
chose to implement a method to create nSLBs from native cell membrane material, which
had recently been developed in our laboratory [118]. This method is based on mechani-
cal disruption of cell membranes to obtain native membrane vesicles (NMVs), which are
sonicated with synthetic vesicles to facilitate vesicle rupture into planar SLBs.
This newly developed nSLB platform was used for the first time to probe virus-cell mem-
brane interactions in paper V. The aim of this paper was to assess the potential of nSLBs
to be used in combination with TIRFM to study HSV-1 binding kinetics and mobility.
To this end, we chose a series of applications aimed at demonstrating the possibility of
using nSLBs for both fundamental interaction studies, as well as for screening of antiviral
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inhibitors. We altered both the expression of viral glycoproteins (using mutant HSV-1 vari-
ants deficient in gC glycoproteins) and the composition of the nSLBs (through enzymatic
removal of HS). For both cases, this led to significant reductions in apparent HSV-1 binding
affinities. Furthermore we used heparin as a model antiviral compound [173], for which we
could estimate the IC50 value, providing a measure of its inhibition efficiency.
(a) (b)
Figure 6.1: (a) The GAG platform (used in paper I - IV) mimics the attachment of GAGs
to proteoglycans in the extracellular matrix and on the cell surface. (b) The nSLB platform
used in paper V is derived from native membrane vesicles, obtained from mechanically dis-
rupted cells, which are incorporated into planar SLBs. (Illustration by Eneas Schmidt)
6.2 Influence of the sulfation of glycosaminoglycans
The main research question addressed in paper I was how the physicochemical properties
of GAGs, in particular the nature of their sulfation, influence the binding characteristics
of HSV-1. Our hypothesis was that besides the number of sulfate groups, their specific
arrangement along the GAG chain could play a significant role during HSV binding. To
verify this hypothesis, we probed binding of single fluorescently labeled HSV-1 particles
to native CS and HS, as well as artificially sulfated sHA, using TIRFM (figure 6.2a). The
recorded time-lapse movies were analyzed using both single particle tracking (SPT), to
study the diffusive behavior of GAG-bound HSV-1 particles, and equilibrium fluctuation
analysis (EFA), to quantify HSV-1 binding kinetics (see chapter 3 for the formalism of SPT
and EFA).
The SPT studies (figure 6.2b,c) revealed complex diffusion characteristics of GAG-bound
HSV-1 particles, presenting both normal and anomalous diffusion modes. While no clear
trend could be resolved for the normal diffusion mode, anomalously diffusing particles,
which also exhibited the fastest diffusion (with diffusion coefficients of up to 0.1 µm2/s),
showed significantly faster diffusion on native CS and HS as compared to sHA. This in-
creased mobility on native GAGs could not be explained by differences in chain or sulfate
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group densities. Indeed, the fastest diffusion was obtained on HS, which also yielded the
highest chain and sulfate group density, although diffusion coefficients are expected to
decrease with the number of bonds [174]. Our findings therefore suggest that the type of
GAG influences HSV mobility, which could be a consequence of both the number and
arrangement of sulfate groups along the GAG chains.
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Figure 6.2: In paper I we studied among others the diffusive behavior of GAG-bound
HSV-1 virions. (a) TIRFM image showing fluorescently labeled HSV-1 particles bound to a
CS-coated surface. Scale bar: 50 µm. (b) Trajectories of the particles in (a) obtained from
SPT analysis. Scale bar: 50 µm. (c) Histogram of diffusion coefficients from anomalously
diffusing HSV-1 particles on CS and sHA.
Association rates, determined by EFA, were in a similar range for CS, HS, and sHA, with
somewhat more particles binding to CS. In comparison, non-sulfated HA yielded 10 times
lower binding, demonstrating the specificity of the HSV-1 interaction to sulfated GAGs.
In an attempt to qualitatively compare binding rates, we calculated association rates per
GAG, which revealed highest binding propensities for CS (∼ 3 times higher in comparison
to sHA), although this GAG had the lowest amount of sulfates per molecule. This result
supports the above stated hypothesis that not only the degree of sulfation of the GAG
chain, but also its type of sulfation influences the affinity of the HSV interaction. Analysis
of the dissociation of particles revealed that only very few particles leave the surface (less
than 0.5% of the bound HSV particles dissociated from the GAG surfaces), highlighting
the efficiency of GAGs in recruiting viruses to the cell surface.
Taken together, paper I demonstrates that both the lateral diffusion and the binding ki-
netics of GAG-bound HSV-1 particles are influenced by the type of GAG, suggesting that
the arrangement of sulfate groups on native GAG chains could play a role in promoting
and modulating HSV binding. Based on our observations, we propose that GAG-bound
HSV particles perform a stochastic “wobbling” movement originating from a gradual ex-
change of bonds between the virus and the GAGs, which does not rely on receptor mobility,
analogous to the recently suggested mechanism of influenza virus A [128]. Although still hy-
pothetical at this point, this lateral diffusion via bond exchange could play an important
role during HSV cell infection, to allow the virus to travel through the extracellular matrix
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and along the cell surface in search for suitable entry sites. As a first step towards confirm-
ing this hypothesis, we performed SPT analysis on HSV-1 particles bound to nSLBs, to
characterize their mobility in a more native-like environment, which includes all membrane
components. A similar diffusive behavior was observed in this case (paper V), with the
main difference that all mobile virions were found to undergo anomalous diffusion. While
it is at this point not clear where this difference stems from, one reason could be that the
contribution to the measured HSV diffusion from mobile surface receptors (often of anoma-
lous nature [175]) is expected to be considerably higher for the nSLB system. The next step
towards demonstrating the biological significance of the observed wobbling movement is to
perform live-cell SPT studies, as further discussed in chapter 7.
6.3 Role of the glycosylation of viral glycoproteins
Paper II - IV address the role of the glycosylation of the viral glycoproteins in modulating
HSV attachment and release to/from the cell surface. In particular, we discuss the function
of so-called mucin-like regions, which have been found, for example, on glycoproteins gC-
1 (on HSV-1) and gG-2 (on HSV-2), forming extended structures of numerous clustered
O-linked glycans. Such highly glycosylated regions have been suggested to protect viruses
from unwanted interactions, for example with neutralizing antibodies [57;58]. The motivation
behind paper II - IV was that the mucin-like regions on gC-1 and gG-2 could play
an essential role in balancing the HSV-GAG interaction. This hypothesis was based on
experiments showing that these domains are affected by serial passages of HSV in cultured
cells in the presence of the GAG mimetic muparfostat (PI-88), inhibitor of HSV binding.
Indeed, for both HSV-1 and HSV-2, several passages resulted in the selection of viral
mutants, which were deficient in the mucin-like domains. In the case of HSV-1 mutants
the gC-1 glycoproteins were truncated, lacking their mucin-like domain [176], while the HSV-
2 mutants were missing the entire gG-2 glycoproteins [177]. These observations suggested
that the presence of mucin-like complexes on viral glycoproteins might influence the HSV-
GAG interaction characteristics. To confirm this hypothesis we used cell-based studies
in combination with the GAG platform, to study HSV binding and release both in their
natural cell environment, and on GAGs only. The case of HSV-1 was studied in paper II
and paper III, while paper IV was dedicated to HSV-2.
6.3.1 HSV-1
The aim of paper II was to investigate the role of the mucin-like domain on gC-1. Our
strategy was to employ HSV-1 variants lacking the entire mucin-like region on the gC
glycoproteins (KOSc-gC∆muc), as well as their corresponding purified gC glycoproteins
(gC∆muc). Electron microscopy studies on infected cells revealed that the number of
spontaneously released KOSc-gC∆muc virions from the surface of infected cells was more
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than 20 times lower than for the wild-type strain. Furthermore, SPR binding studies of
purified gC∆muc glycoproteins to surface-grafted sHA and CS chains (using the GAG
platform as described above) showed that gC∆muc had less of a propensity to bind to
GAGs in comparison to wild-type gC, but that once bound, the gC∆muc-GAG complex
was more stable. In addition, we studied the association of KOSc-gC∆muc to CS using
TIRFM and compared the results to the association of wild-type HSV-1 (KOSc WT)
(figure 6.3a). In agreement with our observations on purified glycoproteins, mutant HSV-1
particles associated to a lesser extent to the GAG surface in comparison to the wild-type
virus (∼ 15% of the KOSc WT association). These findings confirmed our hypothesis
that the mucin-like region on gC-1 modulates the attachment and release of HSV-1 to
GAGs.
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Figure 6.3: Investigating the role of the mucin-like region on gC-1 using (a) TIRFM in
combination with equilibrium fluctuation analysis to measure association kinetics, (b) FD-
based AFM to measure binding forces, (c) TIRFM in combination with SPT to quantify
mobility, and (d) an ELISA-based assay to measure the accessibility of different glycoproteins,
for both the wild-type (KOSc WT) and mutant (KOSc-gC∆muc) HSV-1 virus.
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To further elucidate the role of the mucin-like region on glycoprotein gC of HSV-1, we
investigated how its presence influences the binding forces and diffusive behavior of HSV-1
interacting with CS. These studies, presented in paper III, were performed using FD-
based AFM, and TIRFM in combination with SPT. The AFM results revealed that the
binding forces (representing the force needed to disrupt the virus-GAG interaction) were
overall higher for HSV-1 in the absence of the mucin-like domain on gC (figure 6.3b).
In addition, our SPT studies showed decreased mobility for the HSV-1 mutants (KOSc-
gC∆muc) in comparison to the wild-type (figure 6.3c). These findings are in line with
the results in paper II, demonstrating that the deletion of the mucin-like domain induces
a direct change in binding kinetics of gC∆muc with CS, notably by impairing its ability
to dissociate. This change is expected to affect the overall binding strength of HSV-1
to CS, as well as the ability of the virus to disrupt and reform single bonds, necessary
for its lateral diffusion. Besides affecting gC, the deletion of the mucin-like region could
also alter the contribution to the overall interaction from other glycoproteins, such as gB
and gD. To verify this hypothesis we performed an ELISA-based antibody assay to test
the accessibility of envelope glycoproteins gB, gC, gD, and gE, both in the presence and
in the absence of the mucin-like domain. As shown in figure 6.3d, we observed that the
accessibility of the GAG binding site on gC was reduced on KOSc-gC∆muc as compared to
KOSc WT, while gB and gD showed enhanced accessibility in the absence of the mucin-like
region. The accessibility of gE, which we used as a control, appeared unchanged. These
findings suggest that the mucin-like region on gC promotes GAG interactions via gC, while
shielding possible binding sites on gB and gD. Therefore, it is likely that the deletion of
the mucin-like domain could induce a preferential involvement of gB and gD to the overall
HSV-GAG interaction, which could lead to an increased number of glycoprotein-CS bonds,
contributing to the observed stronger binding and reduced mobility of KOSc-gC∆muc.
Taken together, based on the findings in paper II & III, we postulate that one role of
the mucin-like region on gC is to regulate the attachment of HSV-1 to GAGs by enhancing
initial binding via gC, and preventing premature involvement of gB and gD, likely to result
in trapping of the virus on the cell surface during initial attachment or final egress.
6.3.2 HSV-2
Paper IV was entirely dedicated to HSV-2. The aim was to investigate the role of its
mucin-like glycoprotein gG-2, which was formerly not known to be involved in virus at-
tachment to GAGs. To this end, we performed both cell infection studies, and TIRFM
experiments (using the GAG platform), for which we employed a wild-type HSV-2 virus,
as well as a mutant variant, which completely lacked the gG glycoproteins.
Cell infection experiments showed that gG-deficient HSV-2 mutants were able to infect cells
but yielded ∼ 200 times fewer virus particles in the cell culture medium in comparison to
the HSV-2 wild-type, which was a consequence of the mutants getting trapped on the
surface of infected cells. To complement these findings we used TIRFM in combination
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with EFA and SPT to study binding kinetics and mobility of mutant HSV-2 particles bound
to end-grafted CS chains. While particle dissociation was generally low (less than ∼ 3%
for both virus strains), as already observed for HSV-1 particles in paper I, association
rates were found to be on average ∼ 4.5 times higher for the gG-deficient HSV-2 variants
in comparison to the wild-type (figure 6.4a). Furthermore, the mutant virus exhibited
decreased mobility in comparison to the wild-type (figure 6.3b). These findings indicate
that the mucin-like glycoprotein gG balances the virus interaction with GAGs to prevent
formation of non-reversible bonds leading to trapping of the virus on the cell surface. While
it remains unclear how exactly gG executes this role, we performed antibody binding tests
which showed a reduced accessibility to the binding proteins gC-2 and gB-2 in the presence
of gG. This interesting observation promoted the idea that gG could selectively shield GAG
binding sites on HSV-2 to ensure reversibility of the HSV-GAG interaction, and prevent
trapping.
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Figure 6.4: Paper IV focused on studying the role of the mucin-like gG-2 glycoprotein (on
HSV-2). (a) Association kinetics of wild-type (WT) and mutant (gG-def.) HSV-2 virions to
CS-coated surfaces. (b) Histogram of diffusion coefficients (normal and anomalous diffusion
combined) of the CS-bound HSV-2 virions.
6.3.3 Concluding remarks
Taken together, the results presented in paper II - IV demonstrate that both HSV-1 and
HSV-2 take advantage of the glycosylation of their glycoproteins to balance the interaction
of the virus with cell-surface GAGs during initial attachment and egress. Although the lo-
cation of the mucin-like domains differed between the two serotypes, we found that in both
cases their deletion led to trapping of viral particles on the surface of infected cells, and
a reduced mobility on GAGs. Furthermore, the mucin-like domains were found to shield
other glycoproteins (gB and gD for HSV-1; gB and gC for HSV-2), likely to limit their
50
CHAPTER 6. RESULTS
contribution to GAG binding. Our findings suggest that these highly glycosylated domains
could have one common function, which is to prevent trapping of virions upon initial cell at-
tachment and release. Mucin-like domains form extended structures, frequently containing
negatively charged sialic acid residues, which by steric hindrance and electrostatic repul-
sion with the negatively charged sulfate groups on the GAG chains could contribute to the
reversibility of the HSV-GAG interaction. While our studies only focused on HSV, similar
mucin-like structures have been found on a number of other viruses, including the Ebola
virus, HIV, and the respiratory syncytial virus [57]. It is therefore possible that more viruses,
especially other GAG-binding viruses, use similar mechanisms to promote virus mobility
on the cell surface, and ensure successful liberation of progeny virus after infection.
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7Final reflections and outlook
“Sometimes questions are more important than answers.” – Nancy Willard
The work presented in this thesis is the result of multiple projects and collaborations, all
grouped under one main research aim: to understand the molecular mechanisms of HSV
attachment and release to/from the cell surface. Our strategy was to complement tradi-
tional cell-based assays with bioanalytical platforms, designed to mimic the cell membrane,
in order to characterize HSV-cell membrane interactions on a molecular level. The first
platform, the GAG platform, was a purely artificial model, mimicking the brush-like archi-
tecture of GAGs close to the cell surface. It provided us with the means of characterizing
HSV-GAG interactions in a controlled manner, with the possibility of altering distinct
physicochemical properties of the GAG chains. The second platform was derived directly
from the native cell membrane, thereby creating an interaction environment closer to the
natural cell environment. Both platforms were used mainly in combination with TIRFM,
to study binding kinetics and particle mobility, in order to demonstrate the role of specific
viral and cellular components during cell surface attachment and release.
In this final chapter, two aspects discussed in this thesis will be developed further. The first
one is the use of nSLB systems for virus interaction studies. Paper V demonstrated the
potential of nSLBs to be used both for fundamental virus interaction studies, as well as for
screening of antiviral compounds. For example, the principal involvement of glycoprotein
gC-1 and cellular HS during initial HSV attachment was well established prior to our study,
thanks to traditional cell-based assays, but could be confirmed and quantified using our
native-like model systems. These promising results highlight the potential of nSLBs to be
used in the future to identify the main molecular actors involved in cell attachment for
poorly studied viruses, and new emerging virus strains. Such knowledge is essential to the
development of new antiviral therapies, targeting binding sites on either the virus or the
cell surface to prevent virus attachment. To test such inhibitor compounds, nSLBs can be
used as screening platforms, as confirmed by our inhibition test using heparin. The high
versatility of nSLBs, which can in principle be adapted to any cell line and virus type, will
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hopefully promote their use in the future.
A second aspect, which deserves a more in-depth discussion, is virus mobility, a central
theme in this thesis. Single particle tracking was not initially planned to be part of this the-
sis work, but was included when the early TIRFM movies of HSV-1 binding to GAG-coated
surfaces showed clear signs of lateral diffusion. Our observations led us to propose that
HSV virions, multivalently attached to the GAG chains, undergo a wobbling movement,
caused by the disruption and reformation of single bonds. Although the diffusive behavior
of HSV particles was characterized on model membranes, and is therefore most likely not
fully representative of HSV mobility on live cell membranes, this wobbling movement could
play a significant role during cell infection. Virus binding to the cell membrane is often de-
scribed as a two-step interaction [178]: primary attachment, mediated by weak interactions
between viral proteins and cellular attachment factors (for example electrostatic binding
to GAGs), followed by secondary, non-reversible binding to specific membrane receptors
facilitating cell entry. In the past decade, there has been an increasing number of reports
aiming to elucidate the dynamic processes occurring between primary and secondary at-
tachment. The main question motivating this research is how viruses reach membrane
regions of high receptor densities, which they rely on to become internalized by the cell.
Different possible pathways have been suggested [178], from which one, the land and seek
approach (figure 7.1), postulates that viruses diffuse along the cell membrane immediately
after landing, either as a virus/receptor complex, or alone via disruption and reformation
of bonds, in search for suitable entry sites. Similar mechanisms have been reported for a
number of viruses [68;124–130].
secondary attachment 
/ entry
diffusion
cell membrane
extracellular 
matrix
diffusion
 primary attachment
time
Figure 7.1: Illustration of the land and seek approach, postulating that viruses can diffuse
along the cell membrane immediately after landing in search for suitable entry sites. Based on
the findings of this thesis, we propose that this diffusion could already start in the extracellular
matrix, where gradients of GAG sulfation could guide the virus towards the cell membrane.
Mucin-like domains on the glycoproteins could play an important role during this process to
balance the interactions with GAGs, and prevent premature trapping.
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CHAPTER 7. FINAL REFLECTIONS AND OUTLOOK
While our strategy throughout this thesis was to use model surfaces to confirm and elucidate
results previously obtained from cell-based assays, the reverse approach is needed in this
case. Indeed, to confirm the biological significance of the virus mobility, initially observed
on our cell membrane mimics, it is imperative to move towards cell-based systems, and
perform live-cell SPT studies to monitor the early steps of HSV cell infection. Paper I
suggests that the sulfation of the GAG molecules plays an important role in modulating
diffusion at the cell surface. Therefore one could hypothesize that GAGs play a crucial
role in mediating virus diffusion already in the extracellular matrix, rich in GAGs such as
chondroitin sulfate, where gradients of GAG sulfation could guide the virus towards the
cell surface. During this process, the mucin-like structures of HSV glycoproteins could be
of importance to prevent premature trapping of the virus. Once it reached the cell surface,
the virus could continue diffusing along the surface until it reaches a suitable site for cellular
uptake, maybe inducing a reorganization of viral glycoproteins that leads to the formation
of strong irreversible bonds with membrane receptors, strongly confining the virion. The
above described HSV infection pathway remains hypothetical to this point, but could be
clarified using live-cell imaging, in complement with the cell membrane mimics described
in this thesis. In particular, cell lines with different GAG expression, as well as nSLBs
derived from those cells, could be used to fully decipher the diffusive mechanisms of HSV
during cell infection.
Finally, although this thesis work entirely focused on HSV, it is likely that the here-
discussed findings are, at least partially, transferable to other virus types. The mere fact
that GAGs serve as primary attachment factors for a large number of viruses indicates
that viruses belonging to different families can share common infection pathways. This
thesis therefore aimed at contributing to one main long-term goal, which is an in-depth
understanding of the general viral infection mechanisms, necessary to fight current viral
diseases and future epidemics.
55

Bibliography
[1] International Committee on Taxonomy of Viruses (ICTV) - Master Species
List 2017 v1.0. Retrieved from: https://talk.ictvonline.org/files/master-species-
lists/m/msl/7185, 2018-04-10.
[2] M. J. Roossinck, “The good viruses: Viral mutualistic symbioses,” Nature Reviews
Microbiology, vol. 9, no. 2, pp. 99–108, 2011.
[3] World Health Organization (WHO) - Ebola Situation Report, 10 June 2016. Re-
trieved from: http://www.who.int/csr/disease/ebola/en/, 2018-04-10.
[4] K. N. Bossart, D. L. Fusco, and C. C. Broder, Viral Entry into Host Cells. Springer,
2013.
[5] S. Olofsson and T. Bergstro¨m, “Glycoconjugate glycans as viral receptors,” Annals
of Medicine, vol. 37, no. 3, pp. 154–172, 2005.
[6] R. J. Whitley and B. Roizman, “Herpes simplex virus infections,” The Lancet,
vol. 357, no. 9267, pp. 1513–1518, 2001.
[7] D. WuDunn and P. G. Spear, “Initial interaction of herpes simplex virus with cells
is binding to heparan sulfate,” Journal of Virology, vol. 63, no. 1, pp. 52–58, 1989.
[8] C. Singer, A Short History of Anatomy & Physiology from the Greeks to Harvey.
Dover Publications, Inc., 1957.
[9] R. Phillips, J. Kondev, J. Theriot, and H. G. Garcia, Physical Biology of the Cell.
Garland Science, 2nd ed., 2013.
[10] J. N. Israelachvili, Intermolecular and Surface Forces. Elsevier Inc., 3rd ed., 2011.
[11] B. Kronberg, K. Holmberg, and B. Lindman, Surface Chemistry of Surfactants and
Polymers. Wiley, 2014.
[12] B. Alberts, A. Johnson, and J. Lewis, Molecular Biology of the Cell. Garland Pub-
lishing Inc., 5th ed., 2007.
[13] S. J. J. Singer and G. L. L. Nicolson, “The fluid mosaic model of the structure of cell
membranes,” Science, vol. 175, no. 4023, pp. 720–731, 1972.
[14] J.-F. Tocanne, L. Dupou-Ce´zanne, and A. Lopez, “Lateral diffusion of lipids in model
and natural membranes,”Progress in Lipid Research, vol. 33, no. 3, pp. 203–237, 1994.
57
BIBLIOGRAPHY
[15] M. J. Saxton and K. Jacobsson, “Single-particle tracking: Applications to membrane
dynamics,” Annual review of biophysics and biomolecular structure, vol. 26, pp. 373–
399, 1997.
[16] M. J. Karnovsky, a. M. Kleinfeld, R. L. Hoover, and R. D. Klausner, “The concept
of lipid domains in membranes,” The Journal of cell biology, vol. 94, no. 1, pp. 1–6,
1982.
[17] D. A. Brown and E. London, “Structure and function of sphingolipid- and cholesterol-
rich membrane rafts,” Journal of Biological Chemistry, vol. 275, no. 23, pp. 17221–
17224, 2000.
[18] J. Riethmu¨ller, A. Riehle, H. Grassme´, and E. Gulbins, “Membrane rafts in host-
pathogen interactions,” Biochimica et Biophysica Acta - Biomembranes, vol. 1758,
no. 12, pp. 2139–2147, 2006.
[19] V. Michel and M. Bakovic, “Lipid rafts in health and disease,” Biology of the Cell,
vol. 99, no. 3, pp. 129–140, 2007.
[20] M. L. Kraft, “Plasma membrane organization and function: moving past lipid rafts,”
Molecular Biology of the Cell, vol. 24, no. 18, pp. 2765–2768, 2013.
[21] S. Man˜es, G. Del Real, and C. Mart´ınez-A, “Pathogens: Raft hijackers,” Nature
Reviews Immunology, vol. 3, no. 7, pp. 557–568, 2003.
[22] N. Chazal and D. Gerlier, “Virus Entry, Assembly, Budding, and Membrane Rafts,”
Microbiology and Molecular Biology Reviews, vol. 67, no. 2, pp. 226–237, 2003.
[23] Y. Cheng, M. Li, S. Wang, H. Peng, S. Reid, N. Ni, H. Fang, W. Xu, and B. Wang,
“Carbohydrate biomarkers for future disease detection and treatment,” Science China
Chemistry, vol. 53, no. 1, pp. 3–20, 2010.
[24] R. Apweiler, H. Hermjakob, and N. Sharon, “On the frequency of protein glyco-
sylation, as deduced from analysis of the SWISS-PROT database,” Biochimica et
Biophysica Acta - General Subjects, vol. 1473, no. 1, pp. 4–8, 1999.
[25] A. M. Meledeo, V. D. Paruchuri, J. Du, Z. Wang, and K. J. Yarema, “Mammalian
Glycan Biosynthesis: Building a Template for Biological Recognition,” in Carbo-
hydrate Recognition: Biological Problems, Methods and Applications, ch. 1, Wiley,
2011.
[26] I. Fernaud-Espinosa, M. Nieto-Sampedro, and P. Bovolenta, “Developmental distri-
bution of glycosaminoglycans in embryonic rat brain: Relationship to axonal tract
formation,” Journal of Neurobiology, vol. 30, no. 3, pp. 410–424, 1996.
[27] R. Sasisekharan, Z. Shriver, G. Venkataraman, and U. Narayanasami, “Roles of
heparan-sulphate glycosaminoglycans in cancer,” Nature reviews. Cancer, vol. 2,
no. 7, pp. 521–528, 2002.
58
BIBLIOGRAPHY
[28] T. Uyama, M. Ishida, T. Izumikawa, E. Trybala, F. Tufaro, T. Bergstro¨m, K. Suga-
hara, and H. Kitagawa, “Chondroitin 4-O-sulfotransferase-1 regulates E disaccharide
expression of chondroitin sulfate required for herpes simplex virus infectivity,” Jour-
nal of Biological Chemistry, vol. 281, no. 50, pp. 38668–38674, 2006.
[29] C. I. Gama and L. C. Hsieh-Wilson, “Chemical approaches to deciphering the gly-
cosaminoglycan code,” Current Opinion in Chemical Biology, vol. 9, no. 6, pp. 609–
619, 2005.
[30] J. D. Esko, K. Kimata, and U. Lindahl, “Proteoglycans and Sulfated Glycosamino-
glycans,” in Essentials of Glycobiology, ch. 16, Cold Spring Harbor Laboratory Press,
2 ed., 2009.
[31] L. J. Sto¨h and T. Stehle, “Glycan Engagement by Viruses: Receptor Switches and
Specificity,” Annual Review of Virology, vol. 1, no. 1, p. 140707224641009, 2013.
[32] W. Weis, J. H. Brown, S. Cusack, J. C. Paulson, J. J. Skehel, and D. C. Wiley,
“Structure of the influenza virus haemagglutinin complexed with its receptor, sialic
acid,” Nature, vol. 333, no. 6172, pp. 426–431, 1988.
[33] A. C. S. Saphire, M. D. Bobardt, Z. Zhang, P. A. Gallay, Z. H. E. Zhang, and
G. David, “Syndecans Serve as Attachment Receptors for Human Immunodeficiency
Virus Type 1 on Macrophages,” Journal of Virology, vol. 75, no. 19, pp. 9187–9200,
2001.
[34] B. Salvador, N. R. Sexton, R. Carrion, J. Nunneley, J. L. Patterson, I. Steffen, K. Lu,
M. O. Muench, D. Lembo, and G. Simmons, “Filoviruses utilize glycosaminoglycans
for their attachment to target cells,” Journal of Virology, vol. 87, no. 6, pp. 3295–304,
2013.
[35] S. Y. Kim, J. Zhao, X. Liu, K. Fraser, L. Lin, X. Zhang, F. Zhang, J. S. Dordick,
and R. J. Linhardt, “Interaction of Zika Virus Envelope Protein with Glycosamino-
glycans,” Biochemistry, vol. 56, pp. 1151–1162, 2017.
[36] T. Giroglou, L. Florin, F. Schafer, R. Streeck, and M. Sapp, “Human Papillomavirus
Infection Requires Cell Surface Heparan Sulfate,” Journal of Virology, vol. 75, no. 3,
pp. 1565 – 1570, 2001.
[37] D. R. Harper, Viruses: Biology, Applications and Control. Garland Science, 2012.
[38] J. Carter and V. Saunders, Virology: Principles and Applications. Wiley, 2007.
[39] D. W. White, R. Suzanne Beard, and E. S. Barton, “Immune modulation during
latent herpesvirus infection,” Immunological Reviews, vol. 245, no. 1, pp. 189–208,
2012.
[40] W. E. Lafferty, R. W. Coombs, J. Benedetti, C. Critchlow, and L. Corey,“Recurrences
after oral and genital herpes simplex virus infection. Influence of site of infection and
viral type,” The New England journal of medicine, vol. 316, no. 23, pp. 1444–9, 1987.
59
BIBLIOGRAPHY
[41] World Health Organization (WHO): Herpes simplex virus. Retrieved from:
http://www.who.int/mediacentre/factsheets/fs400/en/, 2018-02-06.
[42] D. J. McGeoch, M. A. Dalrymple, A. J. Davison, A. Dolan, M. C. Frame, D. McNab,
L. J. Perry, J. E. Scott, and P. Taylor, “The complete DNA sequence of the long
unique region in the genome of herpes simplex virus type 1,” Journal of General
Virology, vol. 69, no. 7, pp. 1531–1574, 1988.
[43] A. Dolan, F. E. Jamieson, C. Cunningham, B. C. Barnett, and D. J. McGeoch, “The
genome sequence of herpes simplex virus type 2,” Journal of Virology, vol. 72, no. 3,
pp. 2010–2021, 1998.
[44] C. G. Handler and R. J. Eisenberg, “Oligomeric structure of glycoproteins in herpes
simplex virus type 1,” Journal of Virology, vol. 70, no. 9, pp. 6067–6075, 1996.
[45] B. C. Herold, D. WuDunn, N. Soltys, and P. G. Spear, “Glycoprotein C of herpes
simplex virus type 1 plays a principal role in the adsorption of virus to cells and in
infectivity,” Journal of Virology, vol. 65, no. 3, pp. 1090–8, 1991.
[46] B. W. Banfield, Y. Leduc, L. Esford, R. J. Visalli, C. R. Brandt, and F. Tufaro,
“Evidence for an Interaction of Herpes Simplex Virus with Chondroitin Sulfate Pro-
teoglycans during Infection,” Virology, vol. 208, pp. 531–539, 1995.
[47] K. Ma˚rdberg, E. Trybala, F. Tufaro, and T. Bergstro¨m, “Herpes simplex virus type
1 glycoprotein C is necessary for efficient infection of chondroitin sulfate-expressing
gro2C cells,” Journal of General Virology, vol. 83, no. 2, pp. 291–300, 2002.
[48] B. C. Herold, R. J. Visalli, N. Susmarski, C. R. Brandt, and P. G. Spear, “Glyco-
protein C-independent binding of herpes simplex virus to cells requires cell surface
heparan sulphate and glycoprotein B,” Journal of General Virology, vol. 75, no. 6,
pp. 1211–1222, 1994.
[49] S. I. Gerber, B. J. Belval, and B. C. Herold, “Differences in the role of glycoprotein
C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell
tropism,” Virology, vol. 214, no. 1, pp. 29–39, 1995.
[50] N. Cheshenko and B. C. Herold, “Glycoprotein B plays a predominant role in medi-
ating herpes simplex virus type 2 attachment and is required for entry and cell-to-cell
spread,” Journal of General Virology, vol. 83, no. 9, pp. 2247–2255, 2002.
[51] P. G. Spear, “Herpes simplex virus: Receptors and ligands for cell entry,” Cellular
Microbiology, vol. 6, no. 5, pp. 401–410, 2004.
[52] P. G. Spear, R. J. Eisenberg, and G. H. Cohen, “Three classes of cell surface receptors
for alphaherpesvirus entry,” Virology, vol. 275, no. 1, pp. 1–8, 2000.
[53] A. V. Nicola, A. M. Mcevoy, and S. E. Straus, “Roles for Endocytosis and Low pH in
Herpes Simplex Virus Entry into HeLa and Chinese Hamster Ovary Cells,” Allergy,
vol. 77, no. 9, pp. 5324–5332, 2003.
60
BIBLIOGRAPHY
[54] G. M. Air and W. G. Laver, “The neuraminidase of influenza virus,” Proteins: Struc-
ture, Function and Genetics, vol. 6, no. 4, pp. 341–356, 1989.
[55] S. R. Hadigal, A. M. Agelidis, G. a. Karasneh, T. E. Antoine, A. M. Yakoub, V. C.
Ramani, A. R. Djalilian, R. D. Sanderson, and D. Shukla, “Heparanase is a host en-
zyme required for herpes simplex virus-1 release from cells,” Nature Communications,
pp. 1–11, 2015.
[56] R. Datema, S. Olofsson, and P. A. Romero, “Inhibitors of protein glycosylation and
glycoprotein processing in viral systems,” Pharmacology & Therapeutics, vol. 33,
no. 2-3, pp. 221–286, 1987.
[57] D. J. Vigerust and V. L. Shepherd,“Virus glycosylation: role in virulence and immune
interactions,” Trends in Microbiology, vol. 15, no. 5, pp. 211–218, 2007.
[58] S. Olofsson and J.-E. S. Hansen, “Host cell glycosylation of viral glycoproteins - A
battlefield for host defence and viral resistance,” Scandinavian Journal of Infectious
Diseases, vol. 30, no. 5, 1998.
[59] A. H. Rux, W. T. Moore, J. D. Lambris, W. R. Abrams, C. Peng, H. M. Friedman,
G. H. Cohen, and R. J. Eisenberg, “Disulfide bond structure determination and bio-
chemical analysis of glycoprotein C from herpes simplex virus,” Journal of Virology,
vol. 70, no. 8, pp. 5455–5465, 1996.
[60] A. H. Rux, H. Lou, J. D. Lambris, H. M. Friedman, R. J. Eisenberg, and G. H. Cohen,
“Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to
heparin, heparan sulfate, and complement component C3b,” Virology, vol. 294, no. 2,
pp. 324–32, 2002.
[61] R. J. Goldberg, “A Theory of Antibody-Antigen Reactions. I. Theory for Reactions of
Multivalent Antigen with Bivalent and Univalent Antibody,”Journal of the American
Chemical Society, vol. 74, no. 22, pp. 5715–5725, 1952.
[62] M. Mammen, S. K. Choi, and G. M. Whitesides, “Polyvalent interactions in biolog-
ical systems: Implications for design and use of multivalent ligands and inhibitors,”
Angewandte Chemie-International Edition, vol. 37, no. 20, pp. 2755–2794, 1998.
[63] V. P. Zhdanov, “Multivalent ligand-receptor-mediated interaction of small filled vesi-
cles with a cellular membrane,” Physical Review E, vol. 96, no. 1, pp. 1–10, 2017.
[64] P. Kukura, H. Ewers, C. Mu¨ller, A. Renn, A. Helenius, and V. Sandoghdar, “High-
speed nanoscopic tracking of the position and orientation of a single virus,” Nature
methods, vol. 6, no. 12, pp. 923–927, 2009.
[65] H. Ewers, V. Jacobsen, E. Klotzsch, A. E. Smith, A. Helenius, and V. Sandoghdar,
“Label-free optical detection and tracking of single virions bound to their receptors
in supported membrane bilayers,” Nano Letters, vol. 7, no. 8, pp. 2263–2266, 2007.
61
BIBLIOGRAPHY
[66] O. M. Szklarczyk, N. Gonza´lez-Segredo, P. Kukura, A. Oppenheim, D. Choquet,
V. Sandoghdar, A. Helenius, I. F. Sbalzarini, and H. Ewers, “Receptor Concentration
and Diffusivity Control Multivalent Binding of Sv40 to Membrane Bilayers,” PLoS
Computational Biology, vol. 9, no. 11, pp. 1–16, 2013.
[67] D. Baram-Pinto, S. Shukla, A. Gedanken, and R. Sarid, “Inhibition of HSV-1 attach-
ment, entry, and cell-to-cell spread by functionalized multivalent gold nanoparticles,”
Small, vol. 6, no. 9, pp. 1044–1050, 2010.
[68] E. Rothenberg, L. A. Sepu´lveda, S. O. Skinner, L. Zeng, P. R. Selvin, and I. Gold-
ing, “Single-virus tracking reveals a spatial receptor-dependent search mechanism,”
Biophysical Journal, vol. 100, no. 12, pp. 2875–2882, 2011.
[69] V. Schubertova´, F. J. Martinez-Veracoechea, and R. Va´cha, “Influence of ligand
distribution on uptake efficiency,” Soft Matter, vol. 11, no. 14, pp. 2726–2730, 2015.
[70] A. B. Dahlin, “Kinetics of Molecular Binding to Surfaces,” in Plasmonic Biosensors
- An Integrated View of Refractometric Detection, ch. 3, IOA Press, 2012.
[71] A. V. Hill, “The Combinations of Haemoglobin with Oxygen and with Carbon Monox-
ide,” Biochemical Journal, vol. 7, no. 1, pp. 471–480, 1913.
[72] J. N. Weiss, “The Hill equation revisited: uses and misuses,” The FASEB journal :
official publication of the Federation of American Societies for Experimental Biology,
vol. 11, no. 11, pp. 835–841, 1997.
[73] A. Gunnarsson, P. Jo¨nsson, R. Marie, J. O. Tegenfeldt, and F. Ho¨o¨k, “Single-molecule
detection and mismatch discrimination of unlabeled DNA targets,” Nano Letters,
vol. 8, no. 1, pp. 183–188, 2008.
[74] A. Einstein, “U¨ber die von der molekularkinetischen Theorie der Wa¨rme geforderte
Bewegung von in ruhenden Flu¨ssigkeiten suspendierten Teilchen,” Annalen der
Physik, vol. 332, no. 8, pp. 549–560, 1905.
[75] R. A. Dragovic, C. Gardiner, A. S. Brooks, D. S. Tannetta, D. J. P. Ferguson, P. Hole,
B. Carr, C. W. G. Redman, A. L. Harris, P. J. Dobson, P. Harrison, and I. L. Sargent,
“Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis,”
Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 7, no. 6, pp. 780–788,
2011.
[76] A. Yildiz, “Myosin V Walks Hand-Over-Hand: Single Fluorophore Imaging with 1.5-
nm Localization,” Science, vol. 300, no. 5628, pp. 2061–2065, 2003.
[77] J. Yguerabide, J. A. Schmidt, and E. E. Yguerabide, “Lateral mobility in mem-
branes as detected by fluorescence recovery after photobleaching,” Biophysical jour-
nal, vol. 40, no. 1, pp. 69–75, 1982.
[78] T. K. L. Meyvis, S. C. De Smedt, P. Van Oostveldt, and J. Demeester, “Fluores-
cence recovery after photobleaching: A versatile tool for mobility and interaction
62
BIBLIOGRAPHY
measurements in pharmaceutical research,” Pharmaceutical Research, vol. 16, no. 8,
pp. 1153–1162, 1999.
[79] P. Jo¨nsson, M. P. Jonsson, J. O. Tegenfeldt, and F. Ho¨o¨k, “A method improving the
accuracy of fluorescence recovery after photobleaching analysis,” Biophysical journal,
vol. 95, no. 11, pp. 5334–5348, 2008.
[80] N. Ruthardt, D. C. Lamb, and C. Bra¨uchle, “Single-particle tracking as a quantitative
microscopy-based approach to unravel cell entry mechanisms of viruses and pharma-
ceutical nanoparticles,” Molecular therapy : the journal of the American Society of
Gene Therapy, vol. 19, no. 7, pp. 1199–211, 2011.
[81] C. Bertucci, S. Cimitan, and L. Menotti, “Optical biosensor analysis in studying
herpes simplex virus glycoprotein D binding to target nectin1 receptor,” Journal of
Pharmaceutical and Biomedical Analysis, vol. 32, no. 4-5, pp. 697–706, 2003.
[82] T. Takahashi, S. Kawagishi, M. Masuda, and T. Suzuki, “Binding kinetics of sulfatide
with influenza a virus hemagglutinin,”Glycoconjugate Journal, vol. 30, no. 7, pp. 709–
716, 2013.
[83] S. Pustylnikov, R. S. Dave, Z. K. Khan, V. Porkolab, A. A. Rashad, M. Hutchin-
son, F. Fieschi, I. Chaiken, and P. Jain, “Short Communication: Inhibition of DC-
SIGN-Mediated HIV-1 Infection by Complementary Actions of Dendritic Cell Recep-
tor Antagonists and Env-Targeting Virus Inactivators,” AIDS Research and Human
Retroviruses, vol. 32, no. 1, pp. 93–100, 2016.
[84] C. F. Shuman, M. D. Ha¨ma¨la¨inen, and U. H. Danielson, “Kinetic and thermodynamic
characterization of HIV-1 protease inhibitors,” Journal of molecular recognition :
JMR, vol. 17, no. 2, pp. 106–119, 2004.
[85] D. Massotte, “G protein-coupled receptor overexpression with the baculovirus-insect
cell system: A tool for structural and functional studies,” Biochimica et Biophysica
Acta - Biomembranes, vol. 1610, no. 1, pp. 77–89, 2003.
[86] A. M. Seddon, P. Curnow, and P. J. Booth, “Membrane proteins, lipids and de-
tergents: Not just a soap opera,” Biochimica et Biophysica Acta - Biomembranes,
vol. 1666, no. 1-2, pp. 105–117, 2004.
[87] P. Stenlund, G. J. Babcock, J. Sodroski, and D. G. Myszka, “Capture and reconstitu-
tion of G protein-coupled receptors on a biosensor surface,” Analytical Biochemistry,
vol. 316, no. 2, pp. 243–250, 2003.
[88] U. Bilitewski, “Protein-sensing assay formats and devices,” Analytica Chimica Acta,
vol. 568, no. 1-2, pp. 232–247, 2006.
[89] B. Prieto-Simı´n, M. Campa`s, and J.-L. Marty,“Biomolecule immobilization in biosen-
sor development: tailored strategies based on affinity interactions,” Protein and pep-
tide letters, vol. 15, no. 8, pp. 757–763, 2008.
63
BIBLIOGRAPHY
[90] G. L. Kenausis, J. Vo¨ro¨s, D. L. Elbert, N. Huang, R. Hofer, L. Ruiz-Taylor, M. Tex-
tor, J. A. Hubbell, and N. D. Spencer, “Poly(L-lysine)-g-Poly(ethylene glycol) Layers
on Metal Oxide Surfaces: Attachment Mechanism and Effects of Polymer Architec-
ture on Resistance to Protein Adsorption,” The Journal of Physical Chemistry B,
vol. 104, no. 14, pp. 3298–3309, 2000.
[91] B. Sweryda-Krawiec, H. Devaraj, G. Jacob, and J. J. Hickman,“A New Interpretation
of Serum Albumin Surface Passivation,” Langmuir, vol. 20, no. 6, pp. 2054–2056,
2004.
[92] R. Phillips, T. Ursell, P. Wiggins, and P. Sens, “Emerging roles for lipids in shaping
membrane-protein function,” Nature, vol. 459, no. 7245, pp. 379–385, 2009.
[93] W. Dowhan and M. Bogdanov, “Lipid–protein interactions as determinants of mem-
brane protein structure and function,” Biochemical Society, vol. 39, no. 3, pp. 767–
774, 2011.
[94] C. M. Steffens and T. J. Hope, “Mobility of the Human Immunodeficiency Virus
(HIV) Receptor CD4 and Coreceptor CCR5 in Living Cells : Implications for HIV
Fusion and Entry Events,” Journal of Virology, vol. 78, no. 17, pp. 9573–9578, 2004.
[95] J. M. Johnson, T. Ha, S. Chu, and S. G. Boxer, “Early steps of supported bilayer
formation probed by single vesicle fluorescence assays,” Biophysical Journal, vol. 83,
no. 6, pp. 3371–3379, 2002.
[96] R. P. Richter, R. Be´rat, and A. R. Brisson, “Formation of solid-supported lipid bi-
layers: An integrated view,” Langmuir, vol. 22, no. 8, pp. 3497–3505, 2006.
[97] L. Tamm and H. McConnell, “Supported phospholipid bilayers,” Biophysical Journal,
vol. 47, no. 1, pp. 105–113, 1985.
[98] T. H. Anderson, Y. Min, K. L. Weirich, H. Zeng, D. Fygenson, and J. N. Israelachvili,
“Formation of supported bilayers on silica substrates,” Langmuir, vol. 25, no. 12,
pp. 6997–7005, 2009.
[99] F. Persson, J. Fritzsche, K. U. Mir, M. Modesti, F. Westerlund, and J. O. Tegenfeldt,
“Lipid-based passivation in nanofluidics,” Nano Letters, vol. 12, no. 5, pp. 2260–2265,
2012.
[100] M. Bally, G. E. Rydell, R. Zahn, W. Nasir, C. Eggeling, M. E. Breimer, L. Svensson,
F. Ho¨o¨k, and G. Larson, “Norovirus GII.4 virus-like particles recognize galactosylce-
ramides in domains of planar supported lipid bilayers,” Angewandte Chemie, vol. 51,
no. 48, pp. 12020–4, 2012.
[101] D. W. Lee, H. L. Hsu, K. B. Bacon, and S. Daniel, “Image restoration and analysis
of influenza virions binding to membrane receptors reveal adhesion-strengthening
kinetics,” PLoS ONE, vol. 11, no. 10, pp. 1–27, 2016.
64
BIBLIOGRAPHY
[102] H.-L. Hsu, J. K. Millet, D. A. Costello, G. R. Whittaker, and S. Daniel, “Viral fusion
efficacy of specific H3N2 influenza virus reassortant combinations at single-particle
level,” Scientific Reports, vol. 6, no. 1, p. 35537, 2016.
[103] D. A. Costello, D. W. Lee, J. Drewes, K. A. Vasquez, K. Kisler, U. Wiesner, L. Pol-
lack, G. R. Whittaker, and S. Daniel, “Influenza virus-membrane fusion triggered by
proton uncaging for single particle studies of fusion kinetics,” Analytical Chemistry,
vol. 84, no. 20, pp. 8480–8489, 2012.
[104] L. Simonsson and F. Ho¨o¨k, “Formation and Diffusivity Characterization of Supported
Lipid Bilayers with Complex Lipid Compositions,” Langmuir, vol. 28, pp. 10528–
10533, 2012.
[105] G. J. Hardy, R. Nayak, S. M. Alam, J. G. Shapter, F. Heinrich, S. Zauscher, S. Munir
Alam, J. G. Shapter, F. Heinrich, and S. Zauscher, “Biomimetic supported lipid
bilayers with high cholesterol content formed by α-helical peptide-induced vesicle
fusion,” Journal of Materials Chemistry, vol. 22, no. 37, p. 19506, 2012.
[106] K. Grillitsch, P. Tarazona, L. Klug, T. Wriessnegger, G. Zellnig, E. Leitner, I. Feuss-
ner, and G. Daum, “Isolation and characterization of the plasma membrane from the
yeast Pichia pastoris,” Biochimica et biophysica acta, vol. 1838, no. 7, pp. 1889–97,
2014.
[107] M. Tanaka, F. F. Rossetti, and S. Kaufmann, “Native supported membranes: Cre-
ation of two-dimensional cell membranes on polymer supports (Review),” Biointer-
phases, vol. 3, no. 2, pp. FA12–FA16, 2008.
[108] R. Scott, “Plasma membrane vesiculation: a new technique for isolation of plasma
membranes,” Science, vol. 194, no. 4266, pp. 743–745, 1976.
[109] M. J. Richards, C.-Y. Hsia, R. R. Singh, H. Haider, J. Kumpf, T. Kawate, and
S. Daniel, “Membrane Protein Mobility and Orientation Preserved in Supported Bi-
layers Created Directly from Cell Plasma Membrane Blebs,”Langmuir, vol. 32, no. 12,
pp. 2963–2974, 2016.
[110] A. Grane´li, J. Rydstro¨m, B. Kasemo, and F. Ho¨o¨k, “Formation of Supported Lipid
Bilayer Membranes on SiO2 from Proteoliposomes Containing Transmembrane Pro-
teins,” Langmuir, vol. 19, no. 3, pp. 842–850, 2003.
[111] M. Sundh, S. Svedhem, and D. S. Sutherland, “Influence of phase separating lipids
on supported lipid bilayer formation at SiO2 surfaces,” Physical chemistry chemical
physics : PCCP, vol. 12, no. 2, pp. 453–60, 2010.
[112] G. J. Hardy, R. Nayak, and S. Zauscher, “Model cell membranes: Techniques to form
complex biomimetic supported lipid bilayers via vesicle fusion,” Curr Opin Colloid
Interface Sci., vol. 18, no. 5, pp. 448–458, 2013.
[113] L. Simonsson, A. Gunnarsson, P. Wallin, P. Jo¨nsson, and F. Ho¨o¨k, “Continuous lipid
65
BIBLIOGRAPHY
bilayers derived from cell membranes for spatial molecular manipulation,” Journal of
the American Chemical Society, vol. 133, no. 35, pp. 14027–14032, 2011.
[114] D. A. Costello, C. Y. Hsia, J. K. Millet, T. Porri, and S. Daniel, “Membrane fusion-
competent virus-like proteoliposomes and proteinaceous supported bilayers made di-
rectly from cell plasma membranes,” Langmuir, vol. 29, no. 21, pp. 6409–6419, 2013.
[115] C. E. Dodd, B. R. G. Johnson, L. J. C. Jeuken, T. D. H. Bugg, R. J. Bushby, and
S. D. Evans, “Native E. coli inner membrane incorporation in solid-supported lipid
bilayer membranes,” Biointerphases, vol. 3, no. 2, pp. FA59–FA67, 2008.
[116] H. Y. Liu, W. L. Chen, C. K. Ober, and S. Daniel, “Biologically Complex Planar Cell
Plasma Membranes Supported on Polyelectrolyte Cushions Enhance Transmembrane
Protein Mobility and Retain Native Orientation,” Langmuir, vol. 34, no. 3, pp. 1061–
1072, 2018.
[117] D. A. Costello, J. K. Millet, C. Y. Hsia, G. R. Whittaker, and S. Daniel, “Single
particle assay of coronavirus membrane fusion with proteinaceous receptor-embedded
supported bilayers,” Biomaterials, vol. 34, no. 32, pp. 7895–7904, 2013.
[118] H. Pace, L. Simonsson Nystro¨m, A. Gunnarsson, E. Eck, C. Monson, S. Geschwind-
ner, A. Snijder, and F. Ho¨o¨k, “Preserved Transmembrane Protein Mobility in
Polymer-Supported Lipid Bilayers Derived from Cell Membranes,” Analytical Chem-
istry, vol. 87, no. 18, pp. 9194–9203, 2015.
[119] P. D. Cooper, “The Plaque Assay of Animal Viruses,” in Methods in Virology, vol. 3,
ch. 6, Elsevier Inc., 1967.
[120] R. Dulbecco and M. Vogt, “Some problems of animal virology as studied by the
plaque technique,” Cold Spring Harbor symposia on quantitative biology, vol. 18,
pp. 273–279, 1953.
[121] G. Andrei, R. Snoeck, P. Goubau, J. Desmyter, and E. De Clercq, “Comparative Ac-
tivity of Various Compounds against Clinical Strains of Herpes Simplex Virus,” Eu-
ropean Journal of Clinical Microbiology & Infectious Diseases, vol. 11, no. 2, pp. 143–
151, 1992.
[122] K. Nyberg, M. Ekblad, T. Bergstro¨m, C. Freeman, C. R. Parish, V. Ferro, and
E. Trybala, “The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-
to-cell spread of herpes simplex virus,” Antiviral Research, vol. 63, no. 1, pp. 15–24,
2004.
[123] B. Brandenburg and X. Zhuang,“Virus trafficking - learning from single-viruses track-
ing,” Nat Rev Microbiol., vol. 5, no. 3, pp. 197–208, 2007.
[124] Y.-F. Huang, G.-Y. Zhuo, C.-Y. Chou, C.-H. Lin, W. Chang, and C.-L. Hsieh,“Coher-
ent Brightfield Microscopy Provides the Spatiotemporal Resolution To Study Early
Stage Viral Infection in Live Cells,” ACS Nano, vol. 11, pp. 2575–2585, 2017.
66
BIBLIOGRAPHY
[125] H. M. Van Der Schaar, M. J. Rust, Chen, H. Van Der Ende-Metselaar, J. Wilschut,
X. Zhuang, and J. M. Smit, “Dissecting the cell entry pathway of dengue virus by
single-particle tracking in living cells,” PLoS Pathogens, vol. 4, no. 12, 2008.
[126] P. Liu, M. Ridilla, P. Patel, L. Betts, E. Gallichotte, L. Shahidi, N. L. Thompson,
and K. Jacobson, “Beyond attachment: Roles of DC-SIGN in dengue virus infection,”
Traffic, vol. 18, no. 4, pp. 218–231, 2017.
[127] Y. Gu, Y. Yang, and Y. Liu, “Imaging early steps of sindbis virus infection by total
internal reflection fluorescence microscopy,” Advances in Virology, vol. 2011, 2011.
[128] T. Sakai, S. I. Nishimura, T. Naito, and M. Saito, “Influenza A virus hemagglutinin
and neuraminidase act as novel motile machinery,”Scientific Reports, vol. 7, p. 45043,
2017.
[129] C. J. Burckhardt, M. Suomalainen, P. Schoenenberger, K. Boucke, S. Hemmi, and
U. F. Greber, “Drifting motions of the adenovirus receptor CAR and immobile inte-
grins initiate virus uncoating and membrane lytic protein exposure,” Cell Host and
Microbe, vol. 10, no. 2, pp. 105–117, 2011.
[130] H. Ewers, A. E. Smith, I. F. Sbalzarini, H. Lilie, P. Koumoutsakos, and A. Helenius,
“Single-particle tracking of murine polyoma virus-like particles on live cells and arti-
ficial membranes,” Proceedings of the National Academy of Sciences, vol. 102, no. 42,
pp. 15110–15115, 2005.
[131] J. M. Smit, B. L. Waarts, R. Bittman, and J. Wilschut, “Liposomes as Target Mem-
branes in the Study of Virus Receptor Interaction and Membrane Fusion,” Methods
in Enzymology, vol. 372, pp. 374–392, 2003.
[132] I. Nunes-Correia, A. Eula´lio, S. Nir, N. Du¨zgu¨nes, J. Ramalho-Santos, and M. C.
Pedroso De Lima, “Fluorescent probes for monitoring virus fusion kinetics: Com-
parative evaluation of reliability,” Biochimica et Biophysica Acta - Biomembranes,
vol. 1561, no. 1, pp. 65–75, 2002.
[133] O. Wahlsten, F. Ulander, B. Agnarsson, D. Midtvedt, M. Henningson, V. P. Zhdanov,
and F. Ho¨o¨k, “Quantitative Detection of Biological Nanoparticles in Solution via their
Mediation of Colocalization of Fluorescent Liposomes,” submitted.
[134] B. Liedberg, C. Nylander, and I. Lunstro¨m, “Surface plasmon resonance for gas
detection and biosensing,” Sensors and Actuators, vol. 4, no. C, pp. 299–304, 1983.
[135] N. J. de Mol and M. J. Fischer, “Kinetic and thermodynamic analysis of ligand-
receptor interactions: SPR applications in drug development,” in Handbook of Surface
Plasmon Resonance, ch. 5, Royal Society of Chemistry, 2008.
[136] S. A. Maier, Plasmonics: Fundamentals and applications. Springer, 2007.
[137] B. Liedberg, I. Lundstro¨m, and E. Stenberg, “Principles of biosensing with an ex-
67
BIBLIOGRAPHY
tended coupling matrix and surface plasmon resonance,” Sensors and Actuators B:
Chemical, vol. 11, no. 1-3, pp. 63–72, 1993.
[138] E. Kretschmann, “Die Bestimmung optischer Konstanten von Metallen durch Anre-
gung von Oberfla¨chenplasmaschwingungen,” Zeitschrift fu¨r Physik, vol. 241, no. 4,
pp. 313–324, 1971.
[139] J. De Feijter, J. Benjamins, and F. Veer, “Ellipsometry as a tool to study the ad-
sorption behavior of syntetic and biopolyers at the air water interface,” Biopolymers,
vol. 17, no. 7, pp. 1759–1772, 1978.
[140] L. S. Jung, C. T. Campbell, T. M. Chinowsky, M. N. Mar, and S. S. Yee, “Quan-
titative Interpretation of the Response of Surface Plasmon Resonance Sensors to
Adsorbed Films,” Langmuir, vol. 14, no. 19, pp. 5636–5648, 1998.
[141] J. R. Lakowicz, Principles of fluorescence spectroscopy. Springer, 3rd ed., 2006.
[142] T. Fo¨rster, Z. Energiewanderung, and F. Von, “Zwischenmolekulare Energiewan-
derung und Fluoreszenz,” Annalen der Physik, vol. 248, no. 1938, pp. 55–75, 1939.
[143] C. Berney and G. Danuser, “FRET or no FRET: A quantitative comparison,” Bio-
physical Journal, vol. 84, no. 6, pp. 3992–4010, 2003.
[144] B. Schuler and W. A. Eaton, “Protein folding studied by single-molecule FRET,”
Current Opinion in Structural Biology, vol. 18, no. 1, pp. 16–26, 2008.
[145] D. K. Struck, D. Hoekstra, and R. E. Pagano, “Use of resonance energy transfer to
monitor membrane fusion,” Biochemistry, vol. 20, no. 14, pp. 4093–4099, 1981.
[146] D. Axelrod, “Cell-substrate Contacts Illuminated by Total-Internal Reflection Fluo-
rescence,” Journal of Cell Biology, vol. 89, pp. 141–145, 1981.
[147] D. Axelrod, N. Thompson, and T. P. Burghardt, “Total Internal Reflection Fluores-
cence,” Ann. Rev. Biophysics & Bioengineering, vol. 13, no. 247-268, 1984.
[148] D. Axelrod, “Total Internal Reflection Fluorescence Microscopy,” in Methods in Cell
Biology, vol. 89, ch. 7, Elsevier Inc., 1 ed., 2008.
[149] G. K. Binnig, “Atomic force microscope and method for imaging surfaces with atomic
resolution,” 1988. Patent nr.: US4724318A.
[150] Press Release: The 1986 Nobel Prize in Physics. Retrieved from:
https://www.nobelprize.org/nobel prizes/physics/laureates/1986/press.html ,
2017-12-13.
[151] Y. F. Dufreˆne, “Atomic Force Microscopy , a Powerful Tool in Microbiology,” Journal
of Bacteriology, vol. 184, no. 19, pp. 5205–5213, 2002.
[152] Y. F. Dufreˆne, D. Mart´ınez-Mart´ın, I. Medalsy, D. Alsteens, and D. J. Mu¨ller, “Multi-
68
BIBLIOGRAPHY
parametric imaging of biological systems by force-distance curve-based AFM,”Nature
methods, vol. 10, no. 9, pp. 847–54, 2013.
[153] A. M. Whited and P. S.-H. Park, “Atomic force microscopy: a multifaceted tool to
study membrane proteins and their interactions with ligands,” Biochimica et biophys-
ica acta, vol. 1838, no. 1 Pt A, pp. 56–68, 2014.
[154] E. M. Puchner and H. E. Gaub, “Force and function: probing proteins with AFM-
based force spectroscopy,” Current Opinion in Structural Biology, vol. 19, no. 5,
pp. 605–614, 2009.
[155] D. J. Mu¨ller, H. Janovjak, T. Lehto, L. Kuerschner, and K. Anderson, “Observing
structure, function and assembly of single proteins by AFM,” Progress in Biophysics
and Molecular Biology, vol. 79, no. 1-3, pp. 1–43, 2002.
[156] Y. F. Drygin, O. A. Bordunova, M. O. Gallyamov, and I. V. Yaminsky, “Atomic force
microscopy examination of tobacco mosaic virus and virion RNA,” FEBS Letters,
vol. 425, no. 2, pp. 217–221, 1998.
[157] M. Baclayon, G. J. L. Wuite, and W. H. Roos, “Imaging and manipulation of single
viruses by atomic force microscopy,” Soft Matter, vol. 6, no. 21, p. 5273, 2010.
[158] Y. G. Kuznetsov, C. Xiao, S. Sun, D. Raoult, M. Rossmann, and A. McPherson,
“Atomic force microscopy investigation of the giant mimivirus,” Virology, vol. 404,
no. 1, pp. 127–137, 2010.
[159] Y. L. Lyubchenko, A. A. Gall, L. S. Shlyakhtenko, R. E. Harrington, B. L. Ja-
cobs, P. I. Oden, and S. M. Lindsay, “Atomic force microscopy imaging of double
stranded DNA and RNA,” Journal of biomolecular structure & dynamics, vol. 10,
no. 3, pp. 589–606, 1992.
[160] C. Bustamante, J. Vesenka, C. L. Tang, W. Rees, M. Guthold, and R. Keller, “Cir-
cular DNA molecules imaged in air by scanning force microscopy,” Biochemistry,
vol. 31, no. 1, pp. 22–26, 1992.
[161] B. Cappella and G. Dietler, “Force-distance curves by atomic force microscopy,”
Surface Science Reports, vol. 34, no. 1-3, pp. 1–104, 1999.
[162] R. Barattin and N. Voyer, “Chemical modifications of AFM tips for the study of
molecular recognition events,” Chemical Communications, no. 13, pp. 1513–1532,
2008.
[163] V. T. Moy, E. L. Florin, and H. E. Gaub, “Adhesive forces between ligand and recep-
tor measured by AFM,” Colloids and Surfaces A: Physicochemical and Engineering
Aspects, vol. 93, no. C, pp. 343–348, 1994.
[164] M. Pfreundschuh, D. Alsteens, R. Wieneke, C. Zhang, S. R. Coughlin, R. Tampe´,
B. K. Kobilka, and D. J. Mu¨ller, “Identifying and quantifying two ligand-binding sites
69
BIBLIOGRAPHY
while imaging native human membrane receptors by AFM,” Nature communications,
vol. 6, p. 8857, 2015.
[165] D. Alsteens, M. Pfreundschuh, C. Zhang, P. M. Spoerri, S. R. Coughlin, B. K.
Kobilka, and D. J. Mu¨ller, “Imaging G protein–coupled receptors while quantifying
their ligand-binding free-energy landscape,” Nature Methods, vol. 12, no. 9, pp. 845–
851, 2015.
[166] E. Evans and K. Ritchie, “Dynamic Strength of Moleculer Adhesion Bonds,” Bio-
physical Journal, vol. 72, no. April, pp. 1541–1555, 1997.
[167] E. Evans, “Probing the Relation Between Force—Lifetime—and Chemistry in Single
Molecular Bonds,” Annual Review of Biophysics and Biomolecular Structure, vol. 30,
no. 1, pp. 105–128, 2001.
[168] R. Merkel, P. Nassoy, A. Leung, K. Ritchie, and E. Evans, “Energy landscapes of
receptor-ligand bonds explored with dynamic force spectroscopy,” Nature, vol. 397,
no. 6714, pp. 50–53, 1999.
[169] E. A. Evans and D. A. Calderwood, “Force and bond dynamics in cell adhesion,”
Science, vol. 316, no. 1148, pp. 1148–53, 2007.
[170] D. Alsteens, R. Newton, R. Schubert, D. Martinez-Martin, M. Delguste, B. Roska,
and D. J. Mu¨ller, “Nanomechanical mapping of first binding steps of a virus to animal
cells,” Nature Nanotechnology, vol. 12, no. 2, pp. 177–183, 2017.
[171] N. Altga¨rde, E. Nileba¨ck, L. de Battice, I. Pashkuleva, R. L. Reis, J. Becher, S. Mo¨ller,
M. Schnabelrauch, and S. Svedhem, “Probing the biofunctionality of biotinylated
hyaluronan and chondroitin sulfate by hyaluronidase degradation and aggrecan in-
teraction,” Acta Biomaterialia, vol. 9, no. 9, pp. 8158–8166, 2013.
[172] E. Migliorini, D. Thakar, R. Sadir, T. Pleiner, F. Baleux, H. Lortat-Jacob, L. Coche-
Guerente, and R. P. Richter, “Well-defined biomimetic surfaces to characterize
glycosaminoglycan-mediated interactions on the molecular, supramolecular and cel-
lular levels,” Biomaterials, vol. 35, no. 32, pp. 8903–8915, 2014.
[173] M. Ito, M. Baba, A. Sato, R. Pauwels, E. De Clercq, and S. Shigeta, “Inhibitory
effect of dextran sulfate and heparin on the replication of human immunodeficiency
virus (HIV) in vitro,” Antiviral Research, vol. 7, no. 6, pp. 361–367, 1987.
[174] S. Block, V. P. Zhdanov, and F. Ho¨o¨k, “Quantification of multivalent interactions by
tracking single biological nanoparticle mobility on a lipid membrane,” Nano Letters,
vol. 16, no. 7, pp. 4382–4390, 2016.
[175] P. R. Smith, I. E. Morrison, K. M. Wilson, N. Ferna´ndez, and R. J. Cherry, “Anoma-
lous diffusion of major histocompatibility complex class I molecules on HeLa cells
determined by single particle tracking,” Biophysical Journal, vol. 76, no. 6, pp. 3331–
3344, 1999.
70
BIBLIOGRAPHY
[176] M. Ekblad, B. Adamiak, K. Bergefall, H. Nenonen, A. Roth, T. Bergstrom, V. Ferro,
and E. Trybala, “Molecular basis for resistance of herpes simplex virus type 1 mutants
to the sulfated oligosaccharide inhibitor PI-88,” Virology, vol. 367, no. 2, pp. 244–252,
2007.
[177] B. Adamiak, M. Ekblad, T. Bergstro¨m, V. Ferro, and E. Trybala, “Herpes simplex
virus type 2 glycoprotein G is targeted by the sulfated oligo- and polysaccharide
inhibitors of virus attachment to cells,”Journal of Virology, vol. 81, no. 24, pp. 13424–
13434, 2007.
[178] S. Boulant, M. Stanifer, and P. Y. Lozach, “Dynamics of virus-receptor interactions
in virus binding, signaling, and endocytosis,” Viruses, vol. 7, no. 6, pp. 2794–2815,
2015.
71
